id	sid	tid	token	lemma	pos
gjear-961	1	1	global	global	ADJ
gjear-961	1	2	journal	journal	PROPN
gjear-961	1	3	of	of	ADP
gjear-961	1	4	education	education	NOUN
gjear-961	1	5	and	and	CCONJ
gjear-961	1	6	allied	ally	VERB
gjear-961	1	7	research	research	NOUN
gjear-961	1	8	(	(	PUNCT
gjear-961	1	9	gjear	gjear	NOUN
gjear-961	1	10	)	)	PUNCT
gjear-961	1	11	volume.13	volume.13	PROPN
gjear-961	1	12	,	,	PUNCT
gjear-961	1	13	number	number	NOUN
gjear-961	1	14	12	12	NUM
gjear-961	1	15	;	;	PUNCT
gjear-961	1	16	december-2022	december-2022	NOUN
gjear-961	1	17	;	;	PUNCT
gjear-961	1	18	issn	issn	PROPN
gjear-961	1	19	:	:	PUNCT
gjear-961	1	20	2837	2837	NUM
gjear-961	1	21	-	-	SYM
gjear-961	1	22	3707	3707	NUM
gjear-961	1	23	|	|	NOUN
gjear-961	1	24	impact	impact	NOUN
gjear-961	1	25	factor	factor	NOUN
gjear-961	1	26	:	:	PUNCT
gjear-961	1	27	6.79	6.79	NUM
gjear-961	1	28	https://zapjournals.com/journals/index.php/gjear	https://zapjournals.com/journals/index.php/gjear	NOUN
gjear-961	1	29	published	publish	VERB
gjear-961	1	30	by	by	ADP
gjear-961	1	31	:	:	PUNCT
gjear-961	1	32	zendo	zendo	PROPN
gjear-961	1	33	academic	academic	PROPN
gjear-961	1	34	publishing	publishing	PROPN
gjear-961	1	35	pg	pg	PROPN
gjear-961	1	36	.	.	PROPN
gjear-961	1	37	18	18	NUM
gjear-961	1	38	chromatographic	chromatographic	ADJ
gjear-961	1	39	insights	insight	NOUN
gjear-961	1	40	:	:	PUNCT
gjear-961	1	41	uplc	uplc	PROPN
gjear-961	1	42	-	-	PUNCT
gjear-961	1	43	tuv	tuv	PROPN
gjear-961	1	44	analysis	analysis	NOUN
gjear-961	1	45	of	of	ADP
gjear-961	1	46	glucosamine	glucosamine	NOUN
gjear-961	1	47	and	and	CCONJ
gjear-961	1	48	chondroitin	chondroitin	NOUN
gjear-961	1	49	in	in	ADP
gjear-961	1	50	dietary	dietary	ADJ
gjear-961	1	51	products	product	NOUN
gjear-961	1	52	1dr	1dr	NOUN
gjear-961	1	53	.	.	PUNCT
gjear-961	2	1	nguyen	nguyen	PROPN
gjear-961	2	2	thi	thi	PROPN
gjear-961	2	3	linh	linh	PROPN
gjear-961	2	4	tran	tran	PROPN
gjear-961	2	5	,	,	PUNCT
gjear-961	2	6	2prof	2prof	NUM
gjear-961	2	7	.	.	PUNCT
gjear-961	2	8	le	le	PROPN
gjear-961	2	9	minh	minh	PROPN
gjear-961	2	10	duc	duc	PROPN
gjear-961	2	11	,	,	PUNCT
gjear-961	2	12	3dr	3dr	PROPN
gjear-961	2	13	.	.	PUNCT
gjear-961	3	1	pham	pham	PROPN
gjear-961	3	2	khanh	khanh	PROPN
gjear-961	3	3	nguyen	nguyen	PROPN
gjear-961	3	4	and	and	CCONJ
gjear-961	3	5	4prof	4prof	NUM
gjear-961	3	6	.	.	PUNCT
gjear-961	4	1	nguyen	nguyen	PROPN
gjear-961	4	2	van	van	PROPN
gjear-961	4	3	hoang	hoang	PROPN
gjear-961	4	4	article	article	PROPN
gjear-961	4	5	info	info	NOUN
gjear-961	4	6	abstract	abstract	ADJ
gjear-961	4	7	keywords	keyword	NOUN
gjear-961	4	8	:	:	PUNCT
gjear-961	4	9	osteoarthritis	osteoarthritis	NOUN
gjear-961	4	10	,	,	PUNCT
gjear-961	4	11	glucosamine	glucosamine	NOUN
gjear-961	4	12	,	,	PUNCT
gjear-961	4	13	chondroitin	chondroitin	NOUN
gjear-961	4	14	sulfate	sulfate	NOUN
gjear-961	4	15	,	,	PUNCT
gjear-961	4	16	joint	joint	ADJ
gjear-961	4	17	health	health	NOUN
gjear-961	4	18	,	,	PUNCT
gjear-961	4	19	symptom	symptom	NOUN
gjear-961	4	20	management	management	NOUN
gjear-961	4	21	.	.	PUNCT
gjear-961	5	1	osteoarthritis	osteoarthritis	NOUN
gjear-961	5	2	(	(	PUNCT
gjear-961	5	3	oa	oa	X
gjear-961	5	4	)	)	PUNCT
gjear-961	5	5	is	be	AUX
gjear-961	5	6	a	a	DET
gjear-961	5	7	prevalent	prevalent	ADJ
gjear-961	5	8	chronic	chronic	ADJ
gjear-961	5	9	disease	disease	NOUN
gjear-961	5	10	characterized	characterize	VERB
gjear-961	5	11	by	by	ADP
gjear-961	5	12	irreversible	irreversible	ADJ
gjear-961	5	13	joint	joint	ADJ
gjear-961	5	14	tissue	tissue	NOUN
gjear-961	5	15	damage	damage	NOUN
gjear-961	5	16	,	,	PUNCT
gjear-961	5	17	impacting	impact	VERB
gjear-961	5	18	cartilage	cartilage	NOUN
gjear-961	5	19	,	,	PUNCT
gjear-961	5	20	synovial	synovial	ADJ
gjear-961	5	21	membrane	membrane	NOUN
gjear-961	5	22	,	,	PUNCT
gjear-961	5	23	and	and	CCONJ
gjear-961	5	24	subchondral	subchondral	ADJ
gjear-961	5	25	bone	bone	NOUN
gjear-961	5	26	.	.	PUNCT
gjear-961	6	1	this	this	DET
gjear-961	6	2	study	study	NOUN
gjear-961	6	3	explores	explore	VERB
gjear-961	6	4	the	the	DET
gjear-961	6	5	therapeutic	therapeutic	ADJ
gjear-961	6	6	potential	potential	NOUN
gjear-961	6	7	of	of	ADP
gjear-961	6	8	two	two	NUM
gjear-961	6	9	compounds	compound	NOUN
gjear-961	6	10	,	,	PUNCT
gjear-961	6	11	glucosamine	glucosamine	NOUN
gjear-961	6	12	and	and	CCONJ
gjear-961	6	13	chondroitin	chondroitin	NOUN
gjear-961	6	14	sulfate	sulfate	NOUN
gjear-961	6	15	,	,	PUNCT
gjear-961	6	16	in	in	ADP
gjear-961	6	17	managing	manage	VERB
gjear-961	6	18	oa	oa	PROPN
gjear-961	6	19	symptoms	symptom	NOUN
gjear-961	6	20	.	.	PUNCT
gjear-961	7	1	glucosamine	glucosamine	NOUN
gjear-961	7	2	,	,	PUNCT
gjear-961	7	3	a	a	DET
gjear-961	7	4	vital	vital	ADJ
gjear-961	7	5	component	component	NOUN
gjear-961	7	6	of	of	ADP
gjear-961	7	7	chitin	chitin	NOUN
gjear-961	7	8	and	and	CCONJ
gjear-961	7	9	mucopolysaccharides	mucopolysaccharide	NOUN
gjear-961	7	10	,	,	PUNCT
gjear-961	7	11	is	be	AUX
gjear-961	7	12	known	know	VERB
gjear-961	7	13	for	for	ADP
gjear-961	7	14	its	its	PRON
gjear-961	7	15	role	role	NOUN
gjear-961	7	16	in	in	ADP
gjear-961	7	17	connective	connective	ADJ
gjear-961	7	18	tissue	tissue	NOUN
gjear-961	7	19	and	and	CCONJ
gjear-961	7	20	cartilage	cartilage	NOUN
gjear-961	7	21	formation	formation	NOUN
gjear-961	7	22	.	.	PUNCT
gjear-961	8	1	the	the	DET
gjear-961	8	2	safety	safety	NOUN
gjear-961	8	3	profile	profile	NOUN
gjear-961	8	4	of	of	ADP
gjear-961	8	5	glucosamine	glucosamine	NOUN
gjear-961	8	6	,	,	PUNCT
gjear-961	8	7	as	as	SCONJ
gjear-961	8	8	demonstrated	demonstrate	VERB
gjear-961	8	9	by	by	ADP
gjear-961	8	10	research	research	NOUN
gjear-961	8	11	from	from	ADP
gjear-961	8	12	the	the	DET
gjear-961	8	13	u.s	u.s	PROPN
gjear-961	8	14	.	.	PROPN
gjear-961	8	15	national	national	PROPN
gjear-961	8	16	institutes	institutes	PROPN
gjear-961	8	17	of	of	ADP
gjear-961	8	18	health	health	PROPN
gjear-961	8	19	(	(	PUNCT
gjear-961	8	20	nih	nih	PROPN
gjear-961	8	21	)	)	PUNCT
gjear-961	8	22	and	and	CCONJ
gjear-961	8	23	other	other	ADJ
gjear-961	8	24	sources	source	NOUN
gjear-961	8	25	,	,	PUNCT
gjear-961	8	26	highlights	highlight	VERB
gjear-961	8	27	its	its	PRON
gjear-961	8	28	advantages	advantage	NOUN
gjear-961	8	29	over	over	ADP
gjear-961	8	30	non	non	ADJ
gjear-961	8	31	-	-	ADJ
gjear-961	8	32	steroidal	steroidal	ADJ
gjear-961	8	33	anti	anti	ADJ
gjear-961	8	34	-	-	ADJ
gjear-961	8	35	inflammatory	inflammatory	ADJ
gjear-961	8	36	drugs	drug	NOUN
gjear-961	8	37	(	(	PUNCT
gjear-961	8	38	nsaids	nsaid	NOUN
gjear-961	8	39	)	)	PUNCT
gjear-961	8	40	,	,	PUNCT
gjear-961	8	41	with	with	ADP
gjear-961	8	42	significantly	significantly	ADV
gjear-961	8	43	fewer	few	ADJ
gjear-961	8	44	side	side	ADJ
gjear-961	8	45	effects	effect	NOUN
gjear-961	8	46	observed	observe	VERB
gjear-961	8	47	.	.	PUNCT
gjear-961	9	1	furthermore	furthermore	ADV
gjear-961	9	2	,	,	PUNCT
gjear-961	9	3	glucosamine	glucosamine	NOUN
gjear-961	9	4	does	do	AUX
gjear-961	9	5	not	not	PART
gjear-961	9	6	interfere	interfere	VERB
gjear-961	9	7	with	with	ADP
gjear-961	9	8	glucose	glucose	NOUN
gjear-961	9	9	metabolism	metabolism	NOUN
gjear-961	9	10	.	.	PUNCT
gjear-961	10	1	chondroitin	chondroitin	NOUN
gjear-961	10	2	sulfate	sulfate	NOUN
gjear-961	10	3	,	,	PUNCT
gjear-961	10	4	a	a	DET
gjear-961	10	5	sulfated	sulfated	ADJ
gjear-961	10	6	glycosaminoglycan	glycosaminoglycan	NOUN
gjear-961	10	7	,	,	PUNCT
gjear-961	10	8	is	be	AUX
gjear-961	10	9	widely	widely	ADV
gjear-961	10	10	used	use	VERB
gjear-961	10	11	in	in	ADP
gjear-961	10	12	oa	oa	PROPN
gjear-961	10	13	patient	patient	NOUN
gjear-961	10	14	management	management	NOUN
gjear-961	10	15	.	.	PUNCT
gjear-961	11	1	its	its	PRON
gjear-961	11	2	multifaceted	multifaceted	ADJ
gjear-961	11	3	effects	effect	NOUN
gjear-961	11	4	on	on	ADP
gjear-961	11	5	chondrocyte	chondrocyte	PROPN
gjear-961	11	6	survival	survival	NOUN
gjear-961	11	7	,	,	PUNCT
gjear-961	11	8	modulation	modulation	NOUN
gjear-961	11	9	of	of	ADP
gjear-961	11	10	cartilage	cartilage	NOUN
gjear-961	11	11	matrix	matrix	NOUN
gjear-961	11	12	balance	balance	NOUN
gjear-961	11	13	,	,	PUNCT
gjear-961	11	14	and	and	CCONJ
gjear-961	11	15	reduction	reduction	NOUN
gjear-961	11	16	of	of	ADP
gjear-961	11	17	proinflammatory	proinflammatory	ADJ
gjear-961	11	18	factors	factor	NOUN
gjear-961	11	19	underscore	underscore	VERB
gjear-961	11	20	its	its	PRON
gjear-961	11	21	potential	potential	ADJ
gjear-961	11	22	benefits	benefit	NOUN
gjear-961	11	23	.	.	PUNCT
gjear-961	12	1	in	in	ADP
gjear-961	12	2	subchondral	subchondral	ADJ
gjear-961	12	3	bone	bone	NOUN
gjear-961	12	4	osteoblasts	osteoblast	NOUN
gjear-961	12	5	,	,	PUNCT
gjear-961	12	6	chondroitin	chondroitin	NOUN
gjear-961	12	7	sulfate	sulfate	NOUN
gjear-961	12	8	contributes	contribute	VERB
gjear-961	12	9	to	to	ADP
gjear-961	12	10	enhanced	enhance	VERB
gjear-961	12	11	opg	opg	PROPN
gjear-961	12	12	/	/	SYM
gjear-961	12	13	rankl	rankl	NOUN
gjear-961	12	14	ratio	ratio	NOUN
gjear-961	12	15	,	,	PUNCT
gjear-961	12	16	indicative	indicative	ADJ
gjear-961	12	17	of	of	ADP
gjear-961	12	18	improved	improved	ADJ
gjear-961	12	19	bone	bone	NOUN
gjear-961	12	20	health	health	NOUN
gjear-961	12	21	.	.	PUNCT
gjear-961	13	1	this	this	DET
gjear-961	13	2	review	review	NOUN
gjear-961	13	3	consolidates	consolidate	VERB
gjear-961	13	4	evidence	evidence	NOUN
gjear-961	13	5	on	on	ADP
gjear-961	13	6	the	the	DET
gjear-961	13	7	efficacy	efficacy	NOUN
gjear-961	13	8	and	and	CCONJ
gjear-961	13	9	safety	safety	NOUN
gjear-961	13	10	of	of	ADP
gjear-961	13	11	glucosamine	glucosamine	NOUN
gjear-961	13	12	and	and	CCONJ
gjear-961	13	13	chondroitin	chondroitin	NOUN
gjear-961	13	14	sulfate	sulfate	NOUN
gjear-961	13	15	in	in	ADP
gjear-961	13	16	oa	oa	PROPN
gjear-961	13	17	management	management	NOUN
gjear-961	13	18	,	,	PUNCT
gjear-961	13	19	shedding	shed	VERB
gjear-961	13	20	light	light	NOUN
gjear-961	13	21	on	on	ADP
gjear-961	13	22	their	their	PRON
gjear-961	13	23	roles	role	NOUN
gjear-961	13	24	in	in	ADP
gjear-961	13	25	mitigating	mitigate	VERB
gjear-961	13	26	joint	joint	ADJ
gjear-961	13	27	degeneration	degeneration	NOUN
gjear-961	13	28	and	and	CCONJ
gjear-961	13	29	inflammation	inflammation	NOUN
gjear-961	13	30	.	.	PUNCT
gjear-961	14	1	these	these	DET
gjear-961	14	2	compounds	compound	NOUN
gjear-961	14	3	offer	offer	VERB
gjear-961	14	4	promising	promise	VERB
gjear-961	14	5	avenues	avenue	NOUN
gjear-961	14	6	for	for	ADP
gjear-961	14	7	oa	oa	PROPN
gjear-961	14	8	treatment	treatment	NOUN
gjear-961	14	9	,	,	PUNCT
gjear-961	14	10	warranting	warrant	VERB
gjear-961	14	11	further	further	ADJ
gjear-961	14	12	research	research	NOUN
gjear-961	14	13	and	and	CCONJ
gjear-961	14	14	clinical	clinical	ADJ
gjear-961	14	15	exploration	exploration	NOUN
gjear-961	14	16	.	.	PUNCT
gjear-961	15	1	1	1	X
gjear-961	15	2	.	.	X
gjear-961	15	3	introduction	introduction	NOUN
gjear-961	15	4	osteoarthritis	osteoarthritis	NOUN
gjear-961	15	5	is	be	AUX
gjear-961	15	6	a	a	DET
gjear-961	15	7	chronic	chronic	ADJ
gjear-961	15	8	disease	disease	NOUN
gjear-961	15	9	considered	consider	VERB
gjear-961	15	10	a	a	DET
gjear-961	15	11	global	global	ADJ
gjear-961	15	12	organ	organ	NOUN
gjear-961	15	13	failure	failure	NOUN
gjear-961	15	14	and	and	CCONJ
gjear-961	15	15	characterized	characterize	VERB
gjear-961	15	16	by	by	ADP
gjear-961	15	17	irremediable	irremediable	ADJ
gjear-961	15	18	damage	damage	NOUN
gjear-961	15	19	to	to	ADP
gjear-961	15	20	significant	significant	ADJ
gjear-961	15	21	tissues	tissue	NOUN
gjear-961	15	22	of	of	ADP
gjear-961	15	23	the	the	DET
gjear-961	15	24	joint	joint	ADJ
gjear-961	15	25	,	,	PUNCT
gjear-961	15	26	namely	namely	ADV
gjear-961	15	27	cartilage	cartilage	NOUN
gjear-961	15	28	,	,	PUNCT
gjear-961	15	29	synovial	synovial	ADJ
gjear-961	15	30	membrane	membrane	NOUN
gjear-961	15	31	,	,	PUNCT
gjear-961	15	32	and	and	CCONJ
gjear-961	15	33	subchondral	subchondral	ADJ
gjear-961	15	34	bone	bone	NOUN
gjear-961	15	35	.	.	PUNCT
gjear-961	16	1	the	the	DET
gjear-961	16	2	disease	disease	NOUN
gjear-961	16	3	1,2,3,4	1,2,3,4	NUM
gjear-961	16	4	cantho	cantho	PROPN
gjear-961	16	5	university	university	PROPN
gjear-961	16	6	of	of	ADP
gjear-961	16	7	medicine	medicine	NOUN
gjear-961	16	8	and	and	CCONJ
gjear-961	16	9	pharmacy	pharmacy	NOUN
gjear-961	16	10	,	,	PUNCT
gjear-961	16	11	179	179	NUM
gjear-961	16	12	nguyen	nguyen	NOUN
gjear-961	16	13	van	van	PROPN
gjear-961	16	14	cu	cu	PROPN
gjear-961	16	15	street	street	PROPN
gjear-961	16	16	,	,	PUNCT
gjear-961	16	17	an	an	DET
gjear-961	16	18	khanh	khanh	NOUN
gjear-961	16	19	ward	ward	NOUN
gjear-961	16	20	,	,	PUNCT
gjear-961	16	21	ninh	ninh	PROPN
gjear-961	16	22	kieu	kieu	PROPN
gjear-961	16	23	district	district	PROPN
gjear-961	16	24	,	,	PUNCT
gjear-961	16	25	can	can	AUX
gjear-961	16	26	tho	tho	PROPN
gjear-961	16	27	city	city	PROPN
gjear-961	16	28	,	,	PUNCT
gjear-961	16	29	vietnam	vietnam	PROPN
gjear-961	16	30	https://zapjournals.com/journals/index.php/gjear	https://zapjournals.com/journals/index.php/gjear	PROPN
gjear-961	16	31	global	global	PROPN
gjear-961	16	32	research	research	PROPN
gjear-961	16	33	journal	journal	PROPN
gjear-961	16	34	of	of	ADP
gjear-961	16	35	management	management	NOUN
gjear-961	16	36	and	and	CCONJ
gjear-961	16	37	social	social	ADJ
gjear-961	16	38	sciences	science	NOUN
gjear-961	16	39	(	(	PUNCT
gjear-961	16	40	grjmss	grjmss	PROPN
gjear-961	16	41	)	)	PUNCT
gjear-961	16	42	vol	vol	NOUN
gjear-961	16	43	.	.	PROPN
gjear-961	17	1	13	13	NUM
gjear-961	18	1	(	(	PUNCT
gjear-961	18	2	12	12	NUM
gjear-961	18	3	)	)	PUNCT
gjear-961	18	4	pg	pg	NOUN
gjear-961	18	5	.	.	PROPN
gjear-961	18	6	19	19	NUM
gjear-961	18	7	pathogenesis	pathogenesis	NOUN
gjear-961	18	8	was	be	AUX
gjear-961	18	9	observed	observe	VERB
gjear-961	18	10	,	,	PUNCT
gjear-961	18	11	including	include	VERB
gjear-961	18	12	articular	articular	ADJ
gjear-961	18	13	cartilage	cartilage	NOUN
gjear-961	18	14	loss	loss	NOUN
gjear-961	18	15	,	,	PUNCT
gjear-961	18	16	synovial	synovial	ADJ
gjear-961	18	17	membrane	membrane	NOUN
gjear-961	18	18	inflammation	inflammation	NOUN
gjear-961	18	19	,	,	PUNCT
gjear-961	18	20	and	and	CCONJ
gjear-961	18	21	subchondral	subchondral	ADJ
gjear-961	18	22	bone	bone	NOUN
gjear-961	18	23	alteration	alteration	NOUN
gjear-961	18	24	(	(	PUNCT
gjear-961	18	25	martel	martel	NOUN
gjear-961	18	26	-	-	PUNCT
gjear-961	18	27	pelletier	pelletier	NOUN
gjear-961	18	28	,	,	PUNCT
gjear-961	18	29	2005	2005	NUM
gjear-961	18	30	)	)	PUNCT
gjear-961	18	31	.	.	PUNCT
gjear-961	19	1	glucosamine	glucosamine	NOUN
gjear-961	19	2	,	,	PUNCT
gjear-961	19	3	2	2	NUM
gjear-961	19	4	-	-	SYM
gjear-961	19	5	amino-2	amino-2	NUM
gjear-961	19	6	-	-	PUNCT
gjear-961	19	7	deoxy	deoxy	VERB
gjear-961	19	8	-	-	PUNCT
gjear-961	19	9	d	d	NOUN
gjear-961	19	10	-	-	PUNCT
gjear-961	19	11	glucose	glucose	NOUN
gjear-961	19	12	,	,	PUNCT
gjear-961	19	13	is	be	AUX
gjear-961	19	14	an	an	DET
gjear-961	19	15	essential	essential	ADJ
gjear-961	19	16	part	part	NOUN
gjear-961	19	17	of	of	ADP
gjear-961	19	18	chitin	chitin	NOUN
gjear-961	19	19	and	and	CCONJ
gjear-961	19	20	mucopolysaccharides	mucopolysaccharide	NOUN
gjear-961	19	21	.	.	PUNCT
gjear-961	20	1	large	large	ADJ
gjear-961	20	2	complexes	complex	NOUN
gjear-961	20	3	of	of	ADP
gjear-961	20	4	negatively	negatively	ADV
gjear-961	20	5	charged	charge	VERB
gjear-961	20	6	carbohydrate	carbohydrate	NOUN
gjear-961	20	7	chains	chain	NOUN
gjear-961	20	8	are	be	AUX
gjear-961	20	9	incorporated	incorporate	VERB
gjear-961	20	10	into	into	ADP
gjear-961	20	11	mucous	mucous	ADJ
gjear-961	20	12	secretions	secretion	NOUN
gjear-961	20	13	,	,	PUNCT
gjear-961	20	14	connective	connective	ADJ
gjear-961	20	15	tissue	tissue	NOUN
gjear-961	20	16	,	,	PUNCT
gjear-961	20	17	ligaments	ligament	NOUN
gjear-961	20	18	,	,	PUNCT
gjear-961	20	19	and	and	CCONJ
gjear-961	20	20	cartilage	cartilage	NOUN
gjear-961	20	21	.	.	PUNCT
gjear-961	21	1	glucosamine	glucosamine	NOUN
gjear-961	21	2	is	be	AUX
gjear-961	21	3	also	also	ADV
gjear-961	21	4	a	a	DET
gjear-961	21	5	widely	widely	ADV
gjear-961	21	6	used	use	VERB
gjear-961	21	7	compound	compound	NOUN
gjear-961	21	8	for	for	ADP
gjear-961	21	9	reducing	reduce	VERB
gjear-961	21	10	symptoms	symptom	NOUN
gjear-961	21	11	of	of	ADP
gjear-961	21	12	osteoarthritis	osteoarthritis	NOUN
gjear-961	21	13	.	.	PUNCT
gjear-961	22	1	according	accord	VERB
gjear-961	22	2	to	to	ADP
gjear-961	22	3	u.s	u.s	PROPN
gjear-961	22	4	.	.	PROPN
gjear-961	22	5	national	national	PROPN
gjear-961	22	6	institutes	institutes	PROPN
gjear-961	22	7	of	of	ADP
gjear-961	22	8	health	health	PROPN
gjear-961	22	9	(	(	PUNCT
gjear-961	22	10	nih	nih	PROPN
gjear-961	22	11	)	)	PUNCT
gjear-961	22	12	and	and	CCONJ
gjear-961	22	13	other	other	ADJ
gjear-961	22	14	scientists	scientist	NOUN
gjear-961	22	15	'	'	PART
gjear-961	22	16	research	research	NOUN
gjear-961	22	17	,	,	PUNCT
gjear-961	22	18	side	side	NOUN
gjear-961	22	19	effects	effect	NOUN
gjear-961	22	20	of	of	ADP
gjear-961	22	21	glucosamine	glucosamine	NOUN
gjear-961	22	22	were	be	AUX
gjear-961	22	23	significantly	significantly	ADV
gjear-961	22	24	less	less	ADV
gjear-961	22	25	common	common	ADJ
gjear-961	22	26	than	than	ADP
gjear-961	22	27	non	non	ADJ
gjear-961	22	28	-	-	ADJ
gjear-961	22	29	steroidal	steroidal	ADJ
gjear-961	22	30	antiinflammatory	antiinflammatory	NOUN
gjear-961	22	31	drugs	drug	NOUN
gjear-961	22	32	(	(	PUNCT
gjear-961	22	33	nsaids	nsaid	NOUN
gjear-961	22	34	)	)	PUNCT
gjear-961	22	35	,	,	PUNCT
gjear-961	22	36	significantly	significantly	ADV
gjear-961	22	37	less	less	ADJ
gjear-961	22	38	than	than	ADP
gjear-961	22	39	onethird	onethird	PROPN
gjear-961	22	40	compared	compare	VERB
gjear-961	22	41	to	to	ADP
gjear-961	22	42	ibuprofen	ibuprofen	NOUN
gjear-961	22	43	(	(	PUNCT
gjear-961	22	44	a	a	DET
gjear-961	22	45	commonly	commonly	ADV
gjear-961	22	46	used	use	VERB
gjear-961	22	47	of	of	ADP
gjear-961	22	48	this	this	DET
gjear-961	22	49	group	group	NOUN
gjear-961	22	50	of	of	ADP
gjear-961	22	51	drugs	drug	NOUN
gjear-961	22	52	)	)	PUNCT
gjear-961	22	53	.	.	PUNCT
gjear-961	23	1	its	its	PRON
gjear-961	23	2	safety	safety	NOUN
gjear-961	23	3	was	be	AUX
gjear-961	23	4	proved	prove	VERB
gjear-961	23	5	to	to	PART
gjear-961	23	6	be	be	AUX
gjear-961	23	7	acceptable	acceptable	ADJ
gjear-961	23	8	under	under	ADP
gjear-961	23	9	using	use	VERB
gjear-961	23	10	conditions	condition	NOUN
gjear-961	23	11	and	and	CCONJ
gjear-961	23	12	does	do	AUX
gjear-961	23	13	not	not	PART
gjear-961	23	14	affect	affect	VERB
gjear-961	23	15	glucose	glucose	NOUN
gjear-961	23	16	metabolism	metabolism	NOUN
gjear-961	23	17	(	(	PUNCT
gjear-961	23	18	anderson	anderson	PROPN
gjear-961	23	19	,	,	PUNCT
gjear-961	23	20	2005	2005	NUM
gjear-961	23	21	;	;	PUNCT
gjear-961	23	22	stanley	stanley	NOUN
gjear-961	23	23	,	,	PUNCT
gjear-961	23	24	2004	2004	NUM
gjear-961	23	25	)	)	PUNCT
gjear-961	23	26	.	.	PUNCT
gjear-961	24	1	chondroitin	chondroitin	NOUN
gjear-961	24	2	sulfate	sulfate	NOUN
gjear-961	24	3	is	be	AUX
gjear-961	24	4	a	a	DET
gjear-961	24	5	sulfated	sulfate	VERB
gjear-961	24	6	glycosaminoglycan	glycosaminoglycan	NOUN
gjear-961	24	7	which	which	PRON
gjear-961	24	8	is	be	AUX
gjear-961	24	9	a	a	DET
gjear-961	24	10	long	long	ADJ
gjear-961	24	11	,	,	PUNCT
gjear-961	24	12	unbranched	unbranched	ADJ
gjear-961	24	13	chain	chain	NOUN
gjear-961	24	14	made	make	VERB
gjear-961	24	15	from	from	ADP
gjear-961	24	16	a	a	DET
gjear-961	24	17	repeating	repeat	VERB
gjear-961	24	18	disaccharide	disaccharide	NOUN
gjear-961	24	19	structure	structure	NOUN
gjear-961	24	20	of	of	ADP
gjear-961	24	21	glucuronic	glucuronic	ADJ
gjear-961	24	22	acid	acid	NOUN
gjear-961	24	23	and	and	CCONJ
gjear-961	24	24	n	n	CCONJ
gjear-961	24	25	-	-	PUNCT
gjear-961	24	26	acetyl	acetyl	NOUN
gjear-961	24	27	galactosamine	galactosamine	ADJ
gjear-961	24	28	residues	residue	NOUN
gjear-961	24	29	.	.	PUNCT
gjear-961	25	1	it	it	PRON
gjear-961	25	2	is	be	AUX
gjear-961	25	3	also	also	ADV
gjear-961	25	4	one	one	NUM
gjear-961	25	5	of	of	ADP
gjear-961	25	6	the	the	DET
gjear-961	25	7	most	most	ADV
gjear-961	25	8	widely	widely	ADV
gjear-961	25	9	used	use	VERB
gjear-961	25	10	compounds	compound	NOUN
gjear-961	25	11	in	in	ADP
gjear-961	25	12	managing	manage	VERB
gjear-961	25	13	osteoarthritis	osteoarthritis	NOUN
gjear-961	25	14	patients	patient	NOUN
gjear-961	25	15	.	.	PUNCT
gjear-961	26	1	chondroitin	chondroitin	NOUN
gjear-961	26	2	sulfate	sulfate	NOUN
gjear-961	26	3	has	have	AUX
gjear-961	26	4	been	be	AUX
gjear-961	26	5	shown	show	VERB
gjear-961	26	6	to	to	PART
gjear-961	26	7	change	change	VERB
gjear-961	26	8	the	the	DET
gjear-961	26	9	death	death	NOUN
gjear-961	26	10	process	process	NOUN
gjear-961	26	11	of	of	ADP
gjear-961	26	12	a	a	DET
gjear-961	26	13	chondrocyte	chondrocyte	NOUN
gjear-961	26	14	,	,	PUNCT
gjear-961	26	15	improving	improve	VERB
gjear-961	26	16	the	the	DET
gjear-961	26	17	anabolic	anabolic	NOUN
gjear-961	26	18	/	/	SYM
gjear-961	26	19	catabolic	catabolic	NOUN
gjear-961	26	20	balance	balance	NOUN
gjear-961	26	21	of	of	ADP
gjear-961	26	22	the	the	DET
gjear-961	26	23	extracellular	extracellular	ADJ
gjear-961	26	24	cartilage	cartilage	NOUN
gjear-961	26	25	matrix	matrix	NOUN
gjear-961	26	26	,	,	PUNCT
gjear-961	26	27	reducing	reduce	VERB
gjear-961	26	28	some	some	DET
gjear-961	26	29	proinflammatory	proinflammatory	ADJ
gjear-961	26	30	and	and	CCONJ
gjear-961	26	31	catabolic	catabolic	ADJ
gjear-961	26	32	factors	factor	NOUN
gjear-961	26	33	and	and	CCONJ
gjear-961	26	34	,	,	PUNCT
gjear-961	26	35	in	in	ADP
gjear-961	26	36	subchondral	subchondral	ADJ
gjear-961	26	37	bone	bone	NOUN
gjear-961	26	38	osteoblasts	osteoblast	NOUN
gjear-961	26	39	,	,	PUNCT
gjear-961	26	40	increasing	increase	VERB
gjear-961	26	41	the	the	DET
gjear-961	26	42	ratio	ratio	NOUN
gjear-961	26	43	of	of	ADP
gjear-961	26	44	opg/	opg/	ADJ
gjear-961	26	45	rankl	rankl	NOUN
gjear-961	26	46	(	(	PUNCT
gjear-961	26	47	martel	martel	NOUN
gjear-961	26	48	-	-	PUNCT
gjear-961	26	49	pelletier	pelletier	NOUN
gjear-961	26	50	,	,	PUNCT
gjear-961	26	51	2005	2005	NUM
gjear-961	26	52	)	)	PUNCT
gjear-961	26	53	.	.	PUNCT
gjear-961	27	1	moreover	moreover	ADV
gjear-961	27	2	,	,	PUNCT
gjear-961	27	3	the	the	DET
gjear-961	27	4	long	long	ADJ
gjear-961	27	5	-	-	PUNCT
gjear-961	27	6	term	term	NOUN
gjear-961	27	7	administration	administration	NOUN
gjear-961	27	8	of	of	ADP
gjear-961	27	9	oral	oral	ADJ
gjear-961	27	10	cs	cs	PROPN
gjear-961	27	11	is	be	AUX
gjear-961	27	12	proved	prove	VERB
gjear-961	27	13	to	to	PART
gjear-961	27	14	be	be	AUX
gjear-961	27	15	safe	safe	ADJ
gjear-961	27	16	,	,	PUNCT
gjear-961	27	17	well	well	ADV
gjear-961	27	18	-	-	PUNCT
gjear-961	27	19	tolerated	tolerate	VERB
gjear-961	27	20	,	,	PUNCT
gjear-961	27	21	and	and	CCONJ
gjear-961	27	22	fully	fully	ADV
gjear-961	27	23	indicated	indicate	VERB
gjear-961	27	24	to	to	PART
gjear-961	27	25	control	control	VERB
gjear-961	27	26	the	the	DET
gjear-961	27	27	pain	pain	NOUN
gjear-961	27	28	symptoms	symptom	NOUN
gjear-961	27	29	and	and	CCONJ
gjear-961	27	30	increase	increase	VERB
gjear-961	27	31	the	the	DET
gjear-961	27	32	mobility	mobility	NOUN
gjear-961	27	33	of	of	ADP
gjear-961	27	34	knee	knee	NOUN
gjear-961	27	35	osteoarthritis	osteoarthritis	NOUN
gjear-961	27	36	patients	patient	NOUN
gjear-961	27	37	(	(	PUNCT
gjear-961	27	38	uebelhart	uebelhart	NOUN
gjear-961	27	39	,	,	PUNCT
gjear-961	27	40	2008	2008	NUM
gjear-961	27	41	)	)	PUNCT
gjear-961	27	42	.	.	PUNCT
gjear-961	28	1	ultraperformance	ultraperformance	ADJ
gjear-961	28	2	liquid	liquid	ADJ
gjear-961	28	3	chromatography	chromatography	NOUN
gjear-961	28	4	(	(	PUNCT
gjear-961	28	5	uplc	uplc	ADJ
gjear-961	28	6	)	)	PUNCT
gjear-961	28	7	has	have	AUX
gjear-961	28	8	become	become	VERB
gjear-961	28	9	one	one	NUM
gjear-961	28	10	of	of	ADP
gjear-961	28	11	the	the	DET
gjear-961	28	12	most	most	ADV
gjear-961	28	13	frequently	frequently	ADV
gjear-961	28	14	applied	apply	VERB
gjear-961	28	15	approaches	approach	NOUN
gjear-961	28	16	in	in	ADP
gjear-961	28	17	fast	fast	ADJ
gjear-961	28	18	chromatographic	chromatographic	ADJ
gjear-961	28	19	separations	separation	NOUN
gjear-961	28	20	(	(	PUNCT
gjear-961	28	21	liang	liang	PROPN
gjear-961	28	22	,	,	PUNCT
gjear-961	28	23	2010	2010	NUM
gjear-961	28	24	)	)	PUNCT
gjear-961	28	25	.	.	PUNCT
gjear-961	29	1	hydrophilic	hydrophilic	ADJ
gjear-961	29	2	interaction	interaction	NOUN
gjear-961	29	3	liquid	liquid	ADJ
gjear-961	29	4	chromatography	chromatography	NOUN
gjear-961	29	5	(	(	PUNCT
gjear-961	29	6	hilic	hilic	NOUN
gjear-961	29	7	)	)	PUNCT
gjear-961	29	8	uses	use	VERB
gjear-961	29	9	traditional	traditional	ADJ
gjear-961	29	10	polar	polar	ADJ
gjear-961	29	11	stationary	stationary	ADJ
gjear-961	29	12	phases	phase	NOUN
gjear-961	29	13	,	,	PUNCT
gjear-961	29	14	commonly	commonly	ADV
gjear-961	29	15	applied	apply	VERB
gjear-961	29	16	to	to	PART
gjear-961	29	17	determinate	determinate	VERB
gjear-961	29	18	polar	polar	ADJ
gjear-961	29	19	compounds	compound	NOUN
gjear-961	29	20	,	,	PUNCT
gjear-961	29	21	such	such	ADJ
gjear-961	29	22	as	as	ADP
gjear-961	29	23	pharmaceuticals	pharmaceutical	NOUN
gjear-961	29	24	,	,	PUNCT
gjear-961	29	25	biopharmaceuticals	biopharmaceutical	NOUN
gjear-961	29	26	,	,	PUNCT
gjear-961	29	27	organic	organic	ADJ
gjear-961	29	28	contaminants	contaminant	NOUN
gjear-961	29	29	in	in	ADP
gjear-961	29	30	environmental	environmental	ADJ
gjear-961	29	31	samples	sample	NOUN
gjear-961	29	32	,	,	PUNCT
gjear-961	29	33	and	and	CCONJ
gjear-961	29	34	food	food	NOUN
gjear-961	29	35	components	component	NOUN
gjear-961	29	36	in	in	ADP
gjear-961	29	37	foods	food	NOUN
gjear-961	29	38	(	(	PUNCT
gjear-961	29	39	redón	redón	ADJ
gjear-961	29	40	,	,	PUNCT
gjear-961	29	41	2020	2020	NUM
gjear-961	29	42	)	)	PUNCT
gjear-961	29	43	.	.	PUNCT
gjear-961	30	1	pre	pre	ADJ
gjear-961	30	2	-	-	ADJ
gjear-961	30	3	column	column	ADJ
gjear-961	30	4	derivatization	derivatization	NOUN
gjear-961	30	5	is	be	AUX
gjear-961	30	6	an	an	DET
gjear-961	30	7	efficient	efficient	ADJ
gjear-961	30	8	method	method	NOUN
gjear-961	30	9	that	that	PRON
gjear-961	30	10	produces	produce	VERB
gjear-961	30	11	stable	stable	ADJ
gjear-961	30	12	and	and	CCONJ
gjear-961	30	13	highly	highly	ADV
gjear-961	30	14	fluorescent	fluorescent	ADJ
gjear-961	30	15	derivatives	derivative	NOUN
gjear-961	30	16	for	for	ADP
gjear-961	30	17	analysis	analysis	NOUN
gjear-961	30	18	,	,	PUNCT
gjear-961	30	19	and	and	CCONJ
gjear-961	30	20	the	the	DET
gjear-961	30	21	most	most	ADV
gjear-961	30	22	commonly	commonly	ADV
gjear-961	30	23	used	use	VERB
gjear-961	30	24	derivatization	derivatization	NOUN
gjear-961	30	25	reagent	reagent	NOUN
gjear-961	30	26	for	for	ADP
gjear-961	30	27	this	this	DET
gjear-961	30	28	purpose	purpose	NOUN
gjear-961	30	29	is	be	AUX
gjear-961	30	30	9fluorenylmethyloxycarbonyl	9fluorenylmethyloxycarbonyl	NUM
gjear-961	30	31	chloride	chloride	NOUN
gjear-961	30	32	(	(	PUNCT
gjear-961	30	33	fmoc	fmoc	NOUN
gjear-961	30	34	-	-	PUNCT
gjear-961	30	35	cl	cl	NOUN
gjear-961	30	36	)	)	PUNCT
gjear-961	30	37	(	(	PUNCT
gjear-961	30	38	jámbor	jámbor	NOUN
gjear-961	30	39	,	,	PUNCT
gjear-961	30	40	2009	2009	NUM
gjear-961	30	41	;	;	PUNCT
gjear-961	30	42	molnár	molnár	PROPN
gjear-961	30	43	-	-	NOUN
gjear-961	30	44	perl	perl	NOUN
gjear-961	30	45	,	,	PUNCT
gjear-961	30	46	2011	2011	NUM
gjear-961	30	47	)	)	PUNCT
gjear-961	30	48	.	.	PUNCT
gjear-961	31	1	however	however	ADV
gjear-961	31	2	,	,	PUNCT
gjear-961	31	3	these	these	DET
gjear-961	31	4	methods	method	NOUN
gjear-961	31	5	all	all	PRON
gjear-961	31	6	take	take	VERB
gjear-961	31	7	a	a	DET
gjear-961	31	8	long	long	ADJ
gjear-961	31	9	time	time	NOUN
gjear-961	31	10	and	and	CCONJ
gjear-961	31	11	have	have	VERB
gjear-961	31	12	complex	complex	ADJ
gjear-961	31	13	processing	processing	NOUN
gjear-961	31	14	.	.	PUNCT
gjear-961	32	1	there	there	PRON
gjear-961	32	2	have	have	AUX
gjear-961	32	3	been	be	AUX
gjear-961	32	4	many	many	ADJ
gjear-961	32	5	methods	method	NOUN
gjear-961	32	6	to	to	PART
gjear-961	32	7	quantify	quantify	VERB
gjear-961	32	8	glucosamine	glucosamine	NOUN
gjear-961	32	9	and	and	CCONJ
gjear-961	32	10	chondroitin	chondroitin	NOUN
gjear-961	32	11	on	on	ADP
gjear-961	32	12	different	different	ADJ
gjear-961	32	13	subjects	subject	NOUN
gjear-961	32	14	by	by	ADP
gjear-961	32	15	many	many	ADJ
gjear-961	32	16	techniques	technique	NOUN
gjear-961	32	17	such	such	ADJ
gjear-961	32	18	as	as	ADP
gjear-961	32	19	electrophoresis	electrophoresis	NOUN
gjear-961	32	20	,	,	PUNCT
gjear-961	32	21	high	high	ADJ
gjear-961	32	22	-	-	PUNCT
gjear-961	32	23	performance	performance	NOUN
gjear-961	32	24	liquid	liquid	ADJ
gjear-961	32	25	chromatography	chromatography	NOUN
gjear-961	32	26	combined	combine	VERB
gjear-961	32	27	with	with	ADP
gjear-961	32	28	different	different	ADJ
gjear-961	32	29	detectors	detector	NOUN
gjear-961	32	30	(	(	PUNCT
gjear-961	32	31	hplc	hplc	NOUN
gjear-961	32	32	-	-	PUNCT
gjear-961	32	33	rid	rid	VERB
gjear-961	32	34	,	,	PUNCT
gjear-961	32	35	uv	uv	NOUN
gjear-961	32	36	,	,	PUNCT
gjear-961	32	37	pda	pda	NOUN
gjear-961	32	38	,	,	PUNCT
gjear-961	32	39	fd	fd	PROPN
gjear-961	32	40	)	)	PUNCT
gjear-961	32	41	,	,	PUNCT
gjear-961	32	42	ms	ms	PROPN
gjear-961	32	43	/	/	SYM
gjear-961	32	44	ms	ms	PROPN
gjear-961	32	45	)	)	PUNCT
gjear-961	32	46	(	(	PUNCT
gjear-961	32	47	harmita	harmita	PROPN
gjear-961	32	48	,	,	PUNCT
gjear-961	32	49	2017	2017	NUM
gjear-961	32	50	;	;	PUNCT
gjear-961	32	51	huang	huang	PROPN
gjear-961	32	52	,	,	PUNCT
gjear-961	32	53	2011	2011	NUM
gjear-961	32	54	;	;	PUNCT
gjear-961	32	55	kosman	kosman	NOUN
gjear-961	32	56	,	,	PUNCT
gjear-961	32	57	2017	2017	NUM
gjear-961	32	58	)	)	PUNCT
gjear-961	32	59	.	.	PUNCT
gjear-961	33	1	in	in	ADP
gjear-961	33	2	the	the	DET
gjear-961	33	3	united	united	PROPN
gjear-961	33	4	states	states	PROPN
gjear-961	33	5	pharmacopoeia	pharmacopoeia	PROPN
gjear-961	33	6	(	(	PUNCT
gjear-961	33	7	usp	usp	PROPN
gjear-961	33	8	,	,	PUNCT
gjear-961	33	9	40	40	NUM
gjear-961	33	10	)	)	PUNCT
gjear-961	33	11	,	,	PUNCT
gjear-961	33	12	glucosamine	glucosamine	NOUN
gjear-961	33	13	and	and	CCONJ
gjear-961	33	14	chondroitin	chondroitin	NOUN
gjear-961	33	15	are	be	AUX
gjear-961	33	16	quantified	quantify	VERB
gjear-961	33	17	separately	separately	ADV
gjear-961	33	18	with	with	ADP
gjear-961	33	19	two	two	NUM
gjear-961	33	20	methods	method	NOUN
gjear-961	33	21	,	,	PUNCT
gjear-961	33	22	pda	pda	NOUN
gjear-961	33	23	probe	probe	NOUN
gjear-961	33	24	highperformance	highperformance	NOUN
gjear-961	33	25	liquid	liquid	NOUN
gjear-961	33	26	chromatography	chromatography	NOUN
gjear-961	33	27	,	,	PUNCT
gjear-961	33	28	and	and	CCONJ
gjear-961	33	29	potentiometric	potentiometric	ADJ
gjear-961	33	30	titration	titration	NOUN
gjear-961	33	31	,	,	PUNCT
gjear-961	33	32	respectively	respectively	ADV
gjear-961	33	33	.	.	PUNCT
gjear-961	34	1	while	while	SCONJ
gjear-961	34	2	in	in	ADP
gjear-961	34	3	the	the	DET
gjear-961	34	4	british	british	ADJ
gjear-961	34	5	pharmacopoeia	pharmacopoeia	PROPN
gjear-961	34	6	(	(	PUNCT
gjear-961	34	7	bp	bp	PROPN
gjear-961	34	8	,	,	PUNCT
gjear-961	34	9	2016	2016	NUM
gjear-961	34	10	)	)	PUNCT
gjear-961	34	11	,	,	PUNCT
gjear-961	34	12	quantification	quantification	NOUN
gjear-961	34	13	of	of	ADP
gjear-961	34	14	glucosamine	glucosamine	NOUN
gjear-961	34	15	and	and	CCONJ
gjear-961	34	16	chondroitin	chondroitin	NOUN
gjear-961	34	17	by	by	ADP
gjear-961	34	18	potentiometric	potentiometric	ADJ
gjear-961	34	19	titration	titration	NOUN
gjear-961	34	20	(	(	PUNCT
gjear-961	34	21	usp	usp	PROPN
gjear-961	34	22	,	,	PUNCT
gjear-961	34	23	40	40	NUM
gjear-961	34	24	)	)	PUNCT
gjear-961	34	25	.	.	PUNCT
gjear-961	35	1	according	accord	VERB
gjear-961	35	2	to	to	ADP
gjear-961	35	3	vietnam	vietnam	PROPN
gjear-961	35	4	pharmacopoeia	pharmacopoeia	PROPN
gjear-961	35	5	v	v	PROPN
gjear-961	35	6	(	(	PUNCT
gjear-961	35	7	vmph	vmph	NOUN
gjear-961	35	8	,	,	PUNCT
gjear-961	35	9	2018	2018	NUM
gjear-961	35	10	)	)	PUNCT
gjear-961	35	11	,	,	PUNCT
gjear-961	35	12	glucosamine	glucosamine	NOUN
gjear-961	35	13	is	be	AUX
gjear-961	35	14	determined	determine	VERB
gjear-961	35	15	by	by	ADP
gjear-961	35	16	liquid	liquid	ADJ
gjear-961	35	17	chromatography	chromatography	NOUN
gjear-961	35	18	with	with	ADP
gjear-961	35	19	uv	uv	NOUN
gjear-961	35	20	probe	probe	NOUN
gjear-961	35	21	,	,	PUNCT
gjear-961	35	22	aminopropylsilyl	aminopropylsilyl	PROPN
gjear-961	35	23	silica	silica	NOUN
gjear-961	35	24	gel	gel	NOUN
gjear-961	35	25	column	column	NOUN
gjear-961	35	26	,	,	PUNCT
gjear-961	35	27	but	but	CCONJ
gjear-961	35	28	chondroitin	chondroitin	NOUN
gjear-961	35	29	still	still	ADV
gjear-961	35	30	does	do	AUX
gjear-961	35	31	not	not	PART
gjear-961	35	32	have	have	VERB
gjear-961	35	33	a	a	DET
gjear-961	35	34	process	process	NOUN
gjear-961	35	35	for	for	ADP
gjear-961	35	36	quantification	quantification	NOUN
gjear-961	35	37	.	.	PUNCT
gjear-961	36	1	however	however	ADV
gjear-961	36	2	,	,	PUNCT
gjear-961	36	3	these	these	DET
gjear-961	36	4	methods	method	NOUN
gjear-961	36	5	all	all	PRON
gjear-961	36	6	take	take	VERB
gjear-961	36	7	a	a	DET
gjear-961	36	8	long	long	ADJ
gjear-961	36	9	time	time	NOUN
gjear-961	36	10	and	and	CCONJ
gjear-961	36	11	have	have	VERB
gjear-961	36	12	complex	complex	ADJ
gjear-961	36	13	processing	processing	NOUN
gjear-961	36	14	.	.	PUNCT
gjear-961	37	1	therefore	therefore	ADV
gjear-961	37	2	,	,	PUNCT
gjear-961	37	3	this	this	DET
gjear-961	37	4	study	study	NOUN
gjear-961	37	5	aims	aim	VERB
gjear-961	37	6	to	to	PART
gjear-961	37	7	establish	establish	VERB
gjear-961	37	8	a	a	DET
gjear-961	37	9	quantitative	quantitative	ADJ
gjear-961	37	10	and	and	CCONJ
gjear-961	37	11	straightforward	straightforward	ADJ
gjear-961	37	12	glucosamine	glucosamine	NOUN
gjear-961	37	13	chondroitin	chondroitin	NOUN
gjear-961	37	14	process	process	NOUN
gjear-961	37	15	,	,	PUNCT
gjear-961	37	16	less	less	ADJ
gjear-961	37	17	time	time	NOUN
gjear-961	37	18	analysis	analysis	NOUN
gjear-961	37	19	,	,	PUNCT
gjear-961	37	20	by	by	ADP
gjear-961	37	21	uplc	uplc	PROPN
gjear-961	37	22	-	-	PUNCT
gjear-961	37	23	tuv	tuv	PROPN
gjear-961	37	24	and	and	CCONJ
gjear-961	37	25	precolumn	precolumn	NOUN
gjear-961	37	26	derivatization	derivatization	NOUN
gjear-961	37	27	with	with	ADP
gjear-961	37	28	fmoc	fmoc	NOUN
gjear-961	37	29	-	-	PUNCT
gjear-961	37	30	cl	cl	NOUN
gjear-961	37	31	.	.	NOUN
gjear-961	38	1	2	2	NUM
gjear-961	38	2	.	.	X
gjear-961	38	3	materials	material	NOUN
gjear-961	38	4	and	and	CCONJ
gjear-961	38	5	methods	method	NOUN
gjear-961	38	6	2.1	2.1	NUM
gjear-961	38	7	.	.	PUNCT
gjear-961	39	1	chemicals	chemical	NOUN
gjear-961	39	2	and	and	CCONJ
gjear-961	39	3	materials	material	NOUN
gjear-961	39	4	the	the	DET
gjear-961	39	5	reference	reference	NOUN
gjear-961	39	6	samples	sample	NOUN
gjear-961	39	7	of	of	ADP
gjear-961	39	8	glucosamine	glucosamine	NOUN
gjear-961	39	9	hydrochloride	hydrochloride	NOUN
gjear-961	39	10	(	(	PUNCT
gjear-961	39	11	≥	≥	NUM
gjear-961	39	12	99	99	NUM
gjear-961	39	13	%	%	NOUN
gjear-961	39	14	)	)	PUNCT
gjear-961	39	15	and	and	CCONJ
gjear-961	39	16	chondroitin	chondroitin	NOUN
gjear-961	39	17	sulfate	sulfate	NOUN
gjear-961	39	18	(	(	PUNCT
gjear-961	39	19	≥	≥	NUM
gjear-961	39	20	99	99	NUM
gjear-961	39	21	%	%	NOUN
gjear-961	39	22	)	)	PUNCT
gjear-961	39	23	were	be	AUX
gjear-961	39	24	purchased	purchase	VERB
gjear-961	39	25	from	from	ADP
gjear-961	39	26	sigma	sigma	PROPN
gjear-961	39	27	(	(	PUNCT
gjear-961	39	28	st	st	PROPN
gjear-961	39	29	.	.	PROPN
gjear-961	39	30	louis	louis	PROPN
gjear-961	39	31	,	,	PUNCT
gjear-961	39	32	mo	mo	PROPN
gjear-961	39	33	,	,	PUNCT
gjear-961	39	34	usa	usa	PROPN
gjear-961	39	35	)	)	PUNCT
gjear-961	39	36	.	.	PUNCT
gjear-961	40	1	fluorenylmethyloxycarbonyl	fluorenylmethyloxycarbonyl	ADJ
gjear-961	40	2	chloride	chloride	NOUN
gjear-961	40	3	derivatization	derivatization	NOUN
gjear-961	40	4	reagents	reagent	NOUN
gjear-961	40	5	were	be	AUX
gjear-961	40	6	purchased	purchase	VERB
gjear-961	40	7	from	from	ADP
gjear-961	40	8	sigma	sigma	PROPN
gjear-961	40	9	-	-	PUNCT
gjear-961	40	10	aldrich	aldrich	PROPN
gjear-961	40	11	(	(	PUNCT
gjear-961	40	12	st	st	PROPN
gjear-961	40	13	.	.	PROPN
gjear-961	40	14	louis	louis	PROPN
gjear-961	40	15	,	,	PUNCT
gjear-961	40	16	mo	mo	PROPN
gjear-961	40	17	,	,	PUNCT
gjear-961	40	18	usa	usa	PROPN
gjear-961	40	19	)	)	PUNCT
gjear-961	40	20	.	.	PUNCT
gjear-961	41	1	methanol	methanol	NOUN
gjear-961	41	2	,	,	PUNCT
gjear-961	41	3	acetonitrile	acetonitrile	NOUN
gjear-961	41	4	,	,	PUNCT
gjear-961	41	5	and	and	CCONJ
gjear-961	41	6	hplc	hplc	NOUN
gjear-961	41	7	-	-	PUNCT
gjear-961	41	8	grade	grade	NOUN
gjear-961	41	9	water	water	NOUN
gjear-961	41	10	were	be	AUX
gjear-961	41	11	acquired	acquire	VERB
gjear-961	41	12	from	from	ADP
gjear-961	41	13	honeywell	honeywell	PROPN
gjear-961	41	14	(	(	PUNCT
gjear-961	41	15	north	north	PROPN
gjear-961	41	16	carolina	carolina	PROPN
gjear-961	41	17	,	,	PUNCT
gjear-961	41	18	usa	usa	PROPN
gjear-961	41	19	)	)	PUNCT
gjear-961	41	20	.	.	PUNCT
gjear-961	42	1	ammonium	ammonium	NOUN
gjear-961	42	2	acetate	acetate	NOUN
gjear-961	42	3	,	,	PUNCT
gjear-961	42	4	acid	acid	NOUN
gjear-961	42	5	formic	formic	NOUN
gjear-961	42	6	,	,	PUNCT
gjear-961	42	7	sodium	sodium	NOUN
gjear-961	42	8	hydroxide	hydroxide	NOUN
gjear-961	42	9	,	,	PUNCT
gjear-961	42	10	sodium	sodium	NOUN
gjear-961	42	11	borate	borate	NOUN
gjear-961	42	12	was	be	AUX
gjear-961	42	13	global	global	ADJ
gjear-961	42	14	research	research	NOUN
gjear-961	42	15	journal	journal	PROPN
gjear-961	42	16	of	of	ADP
gjear-961	42	17	management	management	NOUN
gjear-961	42	18	and	and	CCONJ
gjear-961	42	19	social	social	ADJ
gjear-961	42	20	sciences	science	NOUN
gjear-961	42	21	(	(	PUNCT
gjear-961	42	22	grjmss	grjmss	PROPN
gjear-961	42	23	)	)	PUNCT
gjear-961	42	24	vol	vol	NOUN
gjear-961	42	25	.	.	PROPN
gjear-961	42	26	13	13	NUM
gjear-961	42	27	(	(	PUNCT
gjear-961	42	28	12	12	NUM
gjear-961	42	29	)	)	PUNCT
gjear-961	42	30	pg	pg	NOUN
gjear-961	42	31	.	.	PROPN
gjear-961	42	32	20	20	NUM
gjear-961	42	33	purchased	purchase	VERB
gjear-961	42	34	from	from	ADP
gjear-961	42	35	merck	merck	PROPN
gjear-961	42	36	(	(	PUNCT
gjear-961	42	37	darmstadt	darmstadt	PROPN
gjear-961	42	38	,	,	PUNCT
gjear-961	42	39	germany	germany	PROPN
gjear-961	42	40	)	)	PUNCT
gjear-961	42	41	.	.	PUNCT
gjear-961	43	1	the	the	DET
gjear-961	43	2	tablets	tablet	NOUN
gjear-961	43	3	contain	contain	VERB
gjear-961	43	4	two	two	NUM
gjear-961	43	5	active	active	ADJ
gjear-961	43	6	ingredients	ingredient	NOUN
gjear-961	43	7	:	:	PUNCT
gjear-961	43	8	glucosamine	glucosamine	NOUN
gjear-961	43	9	and	and	CCONJ
gjear-961	43	10	chondroitin	chondroitin	NOUN
gjear-961	43	11	.	.	PUNCT
gjear-961	44	1	2.2	2.2	NUM
gjear-961	44	2	.	.	PUNCT
gjear-961	44	3	instrumentation	instrumentation	NOUN
gjear-961	44	4	a	a	DET
gjear-961	44	5	uplc	uplc	ADJ
gjear-961	44	6	acquity	acquity	NOUN
gjear-961	44	7	h	h	NOUN
gjear-961	44	8	-	-	PUNCT
gjear-961	44	9	class	class	NOUN
gjear-961	44	10	system	system	NOUN
gjear-961	44	11	(	(	PUNCT
gjear-961	44	12	waters	water	NOUN
gjear-961	44	13	corporation	corporation	NOUN
gjear-961	44	14	,	,	PUNCT
gjear-961	44	15	massachusetts	massachusetts	PROPN
gjear-961	44	16	,	,	PUNCT
gjear-961	44	17	usa	usa	PROPN
gjear-961	44	18	)	)	PUNCT
gjear-961	44	19	equipped	equip	VERB
gjear-961	44	20	with	with	ADP
gjear-961	44	21	a	a	DET
gjear-961	44	22	tuv	tuv	PROPN
gjear-961	44	23	detector	detector	NOUN
gjear-961	44	24	.	.	PUNCT
gjear-961	45	1	2.3	2.3	NUM
gjear-961	45	2	.	.	PUNCT
gjear-961	45	3	methods	method	NOUN
gjear-961	45	4	according	accord	VERB
gjear-961	45	5	to	to	ADP
gjear-961	45	6	qian	qian	PROPN
gjear-961	45	7	et	et	PROPN
gjear-961	45	8	al	al	PROPN
gjear-961	45	9	.	.	PROPN
gjear-961	46	1	(	(	PUNCT
gjear-961	46	2	2013	2013	NUM
gjear-961	46	3	)	)	PUNCT
gjear-961	46	4	and	and	CCONJ
gjear-961	46	5	the	the	DET
gjear-961	46	6	structures	structure	NOUN
gjear-961	46	7	and	and	CCONJ
gjear-961	46	8	polarities	polarity	NOUN
gjear-961	46	9	of	of	ADP
gjear-961	46	10	analytes	analyte	NOUN
gjear-961	46	11	,	,	PUNCT
gjear-961	46	12	chondroitin	chondroitin	NOUN
gjear-961	46	13	was	be	AUX
gjear-961	46	14	quantified	quantify	VERB
gjear-961	46	15	by	by	ADP
gjear-961	46	16	hilic	hilic	NOUN
gjear-961	46	17	column	column	NOUN
gjear-961	46	18	,	,	PUNCT
gjear-961	46	19	and	and	CCONJ
gjear-961	46	20	glucosamine	glucosamine	NOUN
gjear-961	46	21	was	be	AUX
gjear-961	46	22	determined	determine	VERB
gjear-961	46	23	by	by	ADP
gjear-961	46	24	uplc	uplc	PROPN
gjear-961	46	25	-	-	PUNCT
gjear-961	46	26	tuv	tuv	PROPN
gjear-961	46	27	with	with	ADP
gjear-961	46	28	a	a	DET
gjear-961	46	29	c18	c18	NOUN
gjear-961	46	30	column	column	NOUN
gjear-961	46	31	after	after	ADP
gjear-961	46	32	derivatization	derivatization	NOUN
gjear-961	46	33	with	with	ADP
gjear-961	46	34	9fluorenylmethyloxycarbonyl	9fluorenylmethyloxycarbonyl	NUM
gjear-961	46	35	chloride	chloride	NOUN
gjear-961	46	36	(	(	PUNCT
gjear-961	46	37	michel	michel	PROPN
gjear-961	46	38	,	,	PUNCT
gjear-961	46	39	2004	2004	NUM
gjear-961	46	40	;	;	PUNCT
gjear-961	46	41	qian	qian	PROPN
gjear-961	46	42	,	,	PUNCT
gjear-961	46	43	2013	2013	NUM
gjear-961	46	44	)	)	PUNCT
gjear-961	46	45	.	.	PUNCT
gjear-961	47	1	the	the	DET
gjear-961	47	2	chromatographic	chromatographic	ADJ
gjear-961	47	3	parameters	parameter	NOUN
gjear-961	47	4	,	,	PUNCT
gjear-961	47	5	including	include	VERB
gjear-961	47	6	elution	elution	NOUN
gjear-961	47	7	solvents	solvent	NOUN
gjear-961	47	8	,	,	PUNCT
gjear-961	47	9	mobile	mobile	ADJ
gjear-961	47	10	phase	phase	NOUN
gjear-961	47	11	ratios	ratio	NOUN
gjear-961	47	12	,	,	PUNCT
gjear-961	47	13	detective	detective	NOUN
gjear-961	47	14	wavelengths	wavelength	NOUN
gjear-961	47	15	,	,	PUNCT
gjear-961	47	16	flow	flow	NOUN
gjear-961	47	17	rates	rate	NOUN
gjear-961	47	18	,	,	PUNCT
gjear-961	47	19	and	and	CCONJ
gjear-961	47	20	column	column	NOUN
gjear-961	47	21	temperatures	temperature	NOUN
gjear-961	47	22	,	,	PUNCT
gjear-961	47	23	were	be	AUX
gjear-961	47	24	investigated	investigate	VERB
gjear-961	47	25	.	.	PUNCT
gjear-961	48	1	meanwhile	meanwhile	ADV
gjear-961	48	2	,	,	PUNCT
gjear-961	48	3	the	the	DET
gjear-961	48	4	fmoc	fmoc	NOUN
gjear-961	48	5	-	-	PUNCT
gjear-961	48	6	cl	cl	NOUN
gjear-961	48	7	derivatization	derivatization	NOUN
gjear-961	48	8	conditions	condition	NOUN
gjear-961	48	9	have	have	AUX
gjear-961	48	10	optimized	optimize	VERB
gjear-961	48	11	reaction	reaction	NOUN
gjear-961	48	12	temperatures	temperature	NOUN
gjear-961	48	13	(	(	PUNCT
gjear-961	48	14	30	30	NUM
gjear-961	48	15	°	°	SYM
gjear-961	48	16	c	c	NOUN
gjear-961	48	17	,	,	PUNCT
gjear-961	48	18	50	50	NUM
gjear-961	48	19	°	°	NOUN
gjear-961	48	20	c	c	NOUN
gjear-961	48	21	,	,	PUNCT
gjear-961	48	22	and	and	CCONJ
gjear-961	48	23	70	70	NUM
gjear-961	48	24	°	°	NOUN
gjear-961	48	25	c	c	NOUN
gjear-961	48	26	)	)	PUNCT
gjear-961	48	27	.	.	PUNCT
gjear-961	49	1	preparation	preparation	NOUN
gjear-961	49	2	of	of	ADP
gjear-961	49	3	stock	stock	NOUN
gjear-961	49	4	solutions	solution	NOUN
gjear-961	49	5	.	.	PUNCT
gjear-961	50	1	primary	primary	ADJ
gjear-961	50	2	stock	stock	NOUN
gjear-961	50	3	solutions	solution	NOUN
gjear-961	50	4	of	of	ADP
gjear-961	50	5	glucosamine	glucosamine	NOUN
gjear-961	50	6	and	and	CCONJ
gjear-961	50	7	chondroitin	chondroitin	NOUN
gjear-961	50	8	are	be	AUX
gjear-961	50	9	prepared	prepare	VERB
gjear-961	50	10	with	with	ADP
gjear-961	50	11	methanol	methanol	NOUN
gjear-961	50	12	at	at	ADP
gjear-961	50	13	1000	1000	NUM
gjear-961	50	14	μg	μg	NOUN
gjear-961	50	15	/	/	SYM
gjear-961	50	16	ml	ml	PROPN
gjear-961	50	17	.	.	PUNCT
gjear-961	51	1	working	work	VERB
gjear-961	51	2	solutions	solution	NOUN
gjear-961	51	3	for	for	ADP
gjear-961	51	4	analysis	analysis	NOUN
gjear-961	51	5	and	and	CCONJ
gjear-961	51	6	validation	validation	NOUN
gjear-961	51	7	are	be	AUX
gjear-961	51	8	suitably	suitably	ADV
gjear-961	51	9	diluted	dilute	VERB
gjear-961	51	10	from	from	ADP
gjear-961	51	11	stock	stock	NOUN
gjear-961	51	12	solutions	solution	NOUN
gjear-961	51	13	.	.	PUNCT
gjear-961	52	1	preparation	preparation	NOUN
gjear-961	52	2	of	of	ADP
gjear-961	52	3	reagent	reagent	ADJ
gjear-961	52	4	solutions	solution	NOUN
gjear-961	52	5	.	.	PUNCT
gjear-961	53	1	fmoc	fmoc	NOUN
gjear-961	53	2	-	-	PUNCT
gjear-961	53	3	cl	cl	NOUN
gjear-961	53	4	is	be	AUX
gjear-961	53	5	dissolved	dissolve	VERB
gjear-961	53	6	in	in	ADP
gjear-961	53	7	acetonitrile	acetonitrile	NOUN
gjear-961	53	8	at	at	ADP
gjear-961	53	9	1500	1500	NUM
gjear-961	53	10	μg	μg	NOUN
gjear-961	53	11	/	/	SYM
gjear-961	53	12	ml	ml	PROPN
gjear-961	53	13	.	.	PUNCT
gjear-961	54	1	methods	method	NOUN
gjear-961	54	2	validation	validation	NOUN
gjear-961	54	3	.	.	PUNCT
gjear-961	55	1	according	accord	VERB
gjear-961	55	2	to	to	ADP
gjear-961	55	3	ich	ich	NOUN
gjear-961	55	4	guidelines	guideline	NOUN
gjear-961	55	5	,	,	PUNCT
gjear-961	55	6	the	the	DET
gjear-961	55	7	proposed	propose	VERB
gjear-961	55	8	method	method	NOUN
gjear-961	55	9	was	be	AUX
gjear-961	55	10	validated	validate	VERB
gjear-961	55	11	for	for	ADP
gjear-961	55	12	selectivity	selectivity	NOUN
gjear-961	55	13	,	,	PUNCT
gjear-961	55	14	linearity	linearity	NOUN
gjear-961	55	15	,	,	PUNCT
gjear-961	55	16	the	the	DET
gjear-961	55	17	limit	limit	NOUN
gjear-961	55	18	of	of	ADP
gjear-961	55	19	detection	detection	NOUN
gjear-961	55	20	(	(	PUNCT
gjear-961	55	21	lod	lod	PROPN
gjear-961	55	22	)	)	PUNCT
gjear-961	55	23	,	,	PUNCT
gjear-961	55	24	quantification	quantification	NOUN
gjear-961	55	25	(	(	PUNCT
gjear-961	55	26	loq	loq	PROPN
gjear-961	55	27	)	)	PUNCT
gjear-961	55	28	,	,	PUNCT
gjear-961	55	29	precision	precision	NOUN
gjear-961	55	30	,	,	PUNCT
gjear-961	55	31	and	and	CCONJ
gjear-961	55	32	accuracy	accuracy	NOUN
gjear-961	55	33	.	.	PUNCT
gjear-961	56	1	3	3	X
gjear-961	56	2	.	.	NOUN
gjear-961	56	3	results	result	NOUN
gjear-961	56	4	and	and	CCONJ
gjear-961	56	5	discussion	discussion	NOUN
gjear-961	56	6	3.1	3.1	NUM
gjear-961	56	7	.	.	PUNCT
gjear-961	57	1	methods	method	NOUN
gjear-961	57	2	development	development	VERB
gjear-961	57	3	the	the	DET
gjear-961	57	4	high	high	ADJ
gjear-961	57	5	polarity	polarity	NOUN
gjear-961	57	6	of	of	ADP
gjear-961	57	7	the	the	DET
gjear-961	57	8	determined	determined	ADJ
gjear-961	57	9	compounds	compound	NOUN
gjear-961	57	10	made	make	VERB
gjear-961	57	11	it	it	PRON
gjear-961	57	12	challenging	challenging	ADJ
gjear-961	57	13	to	to	PART
gjear-961	57	14	optimize	optimize	VERB
gjear-961	57	15	chromatographic	chromatographic	ADJ
gjear-961	57	16	separation	separation	NOUN
gjear-961	57	17	(	(	PUNCT
gjear-961	57	18	huang	huang	PROPN
gjear-961	57	19	,	,	PUNCT
gjear-961	57	20	2006	2006	NUM
gjear-961	57	21	;	;	PUNCT
gjear-961	57	22	václavíková	václavíková	X
gjear-961	57	23	,	,	PUNCT
gjear-961	57	24	2015	2015	NUM
gjear-961	57	25	)	)	PUNCT
gjear-961	57	26	.	.	PUNCT
gjear-961	58	1	on	on	ADP
gjear-961	58	2	the	the	DET
gjear-961	58	3	other	other	ADJ
gjear-961	58	4	hand	hand	NOUN
gjear-961	58	5	,	,	PUNCT
gjear-961	58	6	the	the	DET
gjear-961	58	7	molecular	molecular	ADJ
gjear-961	58	8	weight	weight	NOUN
gjear-961	58	9	of	of	ADP
gjear-961	58	10	glucosamine	glucosamine	NOUN
gjear-961	58	11	and	and	CCONJ
gjear-961	58	12	chondroitin	chondroitin	NOUN
gjear-961	58	13	is	be	AUX
gjear-961	58	14	also	also	ADV
gjear-961	58	15	a	a	DET
gjear-961	58	16	problem	problem	NOUN
gjear-961	58	17	for	for	ADP
gjear-961	58	18	hplc	hplc	NOUN
gjear-961	58	19	quantification	quantification	NOUN
gjear-961	58	20	.	.	PUNCT
gjear-961	59	1	establishing	establish	VERB
gjear-961	59	2	and	and	CCONJ
gjear-961	59	3	optimizing	optimize	VERB
gjear-961	59	4	the	the	DET
gjear-961	59	5	analysis	analysis	NOUN
gjear-961	59	6	process	process	NOUN
gjear-961	59	7	,	,	PUNCT
gjear-961	59	8	therefore	therefore	ADV
gjear-961	59	9	,	,	PUNCT
gjear-961	59	10	becomes	become	VERB
gjear-961	59	11	much	much	ADV
gjear-961	59	12	more	more	ADV
gjear-961	59	13	necessary	necessary	ADJ
gjear-961	59	14	.	.	PUNCT
gjear-961	60	1	according	accord	VERB
gjear-961	60	2	to	to	ADP
gjear-961	60	3	government	government	NOUN
gjear-961	60	4	chemist	chemist	NOUN
gjear-961	60	5	(	(	PUNCT
gjear-961	60	6	2012	2012	NUM
gjear-961	60	7	)	)	PUNCT
gjear-961	60	8	,	,	PUNCT
gjear-961	60	9	chondroitin	chondroitin	NOUN
gjear-961	60	10	determination	determination	NOUN
gjear-961	60	11	has	have	VERB
gjear-961	60	12	several	several	ADJ
gjear-961	60	13	typical	typical	ADJ
gjear-961	60	14	approaches	approach	NOUN
gjear-961	60	15	,	,	PUNCT
gjear-961	60	16	such	such	ADJ
gjear-961	60	17	as	as	ADP
gjear-961	60	18	high	high	ADJ
gjear-961	60	19	-	-	PUNCT
gjear-961	60	20	performance	performance	NOUN
gjear-961	60	21	liquid	liquid	NOUN
gjear-961	60	22	(	(	PUNCT
gjear-961	60	23	hplc	hplc	NOUN
gjear-961	60	24	)	)	PUNCT
gjear-961	60	25	methods	method	NOUN
gjear-961	60	26	based	base	VERB
gjear-961	60	27	on	on	ADP
gjear-961	60	28	size	size	NOUN
gjear-961	60	29	exclusion	exclusion	NOUN
gjear-961	60	30	and	and	CCONJ
gjear-961	60	31	using	use	VERB
gjear-961	60	32	amine	amine	ADJ
gjear-961	60	33	column	column	NOUN
gjear-961	60	34	or	or	CCONJ
gjear-961	60	35	ion	ion	NOUN
gjear-961	60	36	exchange	exchange	NOUN
gjear-961	60	37	hplc	hplc	NOUN
gjear-961	60	38	.	.	PUNCT
gjear-961	61	1	meanwhile	meanwhile	ADV
gjear-961	61	2	,	,	PUNCT
gjear-961	61	3	glucosamine	glucosamine	NOUN
gjear-961	61	4	also	also	ADV
gjear-961	61	5	has	have	AUX
gjear-961	61	6	been	be	AUX
gjear-961	61	7	researched	research	VERB
gjear-961	61	8	by	by	ADP
gjear-961	61	9	an	an	DET
gjear-961	61	10	extensive	extensive	ADJ
gjear-961	61	11	range	range	NOUN
gjear-961	61	12	of	of	ADP
gjear-961	61	13	methods	method	NOUN
gjear-961	61	14	like	like	ADP
gjear-961	61	15	gas	gas	NOUN
gjear-961	61	16	chromatography	chromatography	NOUN
gjear-961	61	17	,	,	PUNCT
gjear-961	61	18	liquid	liquid	ADJ
gjear-961	61	19	chromatography	chromatography	NOUN
gjear-961	61	20	-	-	PUNCT
gjear-961	61	21	tandem	tandem	NOUN
gjear-961	61	22	mass	mass	PROPN
gjear-961	61	23	spectral	spectral	ADJ
gjear-961	61	24	,	,	PUNCT
gjear-961	61	25	and	and	CCONJ
gjear-961	61	26	one	one	NUM
gjear-961	61	27	of	of	ADP
gjear-961	61	28	the	the	DET
gjear-961	61	29	most	most	ADV
gjear-961	61	30	effective	effective	ADJ
gjear-961	61	31	methods	method	NOUN
gjear-961	61	32	that	that	PRON
gjear-961	61	33	have	have	AUX
gjear-961	61	34	been	be	AUX
gjear-961	61	35	reported	report	VERB
gjear-961	61	36	is	be	AUX
gjear-961	61	37	highperformance	highperformance	NOUN
gjear-961	61	38	chromatography	chromatography	NOUN
gjear-961	61	39	method	method	NOUN
gjear-961	61	40	involving	involve	VERB
gjear-961	61	41	derivatization	derivatization	NOUN
gjear-961	61	42	with	with	ADP
gjear-961	61	43	fmoc	fmoc	NOUN
gjear-961	61	44	-	-	PUNCT
gjear-961	61	45	cl	cl	NOUN
gjear-961	61	46	(	(	PUNCT
gjear-961	61	47	huang	huang	PROPN
gjear-961	61	48	,	,	PUNCT
gjear-961	61	49	2006	2006	NUM
gjear-961	61	50	)	)	PUNCT
gjear-961	61	51	.	.	PUNCT
gjear-961	62	1	3.1.1	3.1.1	X
gjear-961	62	2	.	.	PUNCT
gjear-961	62	3	chondroitin	chondroitin	NOUN
gjear-961	62	4	quantification	quantification	NOUN
gjear-961	62	5	the	the	DET
gjear-961	62	6	survey	survey	NOUN
gjear-961	62	7	results	result	NOUN
gjear-961	62	8	showed	show	VERB
gjear-961	62	9	that	that	SCONJ
gjear-961	62	10	aliquots	aliquot	NOUN
gjear-961	62	11	of	of	ADP
gjear-961	62	12	the	the	DET
gjear-961	62	13	process	process	NOUN
gjear-961	62	14	samples	sample	NOUN
gjear-961	62	15	(	(	PUNCT
gjear-961	62	16	10	10	NUM
gjear-961	62	17	μl	μl	PRON
gjear-961	62	18	)	)	PUNCT
gjear-961	62	19	were	be	AUX
gjear-961	62	20	injected	inject	VERB
gjear-961	62	21	into	into	ADP
gjear-961	62	22	column	column	NOUN
gjear-961	62	23	-	-	PUNCT
gjear-961	62	24	a	a	DET
gjear-961	62	25	beh	beh	NOUN
gjear-961	62	26	hilic	hilic	NOUN
gjear-961	62	27	column	column	NOUN
gjear-961	62	28	(	(	PUNCT
gjear-961	62	29	2.1	2.1	NUM
gjear-961	62	30	×	×	NOUN
gjear-961	62	31	100	100	NUM
gjear-961	62	32	mm	mm	NOUN
gjear-961	62	33	,	,	PUNCT
gjear-961	62	34	1.7	1.7	NUM
gjear-961	62	35	μm	μm	NUM
gjear-961	62	36	)	)	PUNCT
gjear-961	62	37	with	with	ADP
gjear-961	62	38	mobile	mobile	ADJ
gjear-961	62	39	phase	phase	NOUN
gjear-961	62	40	,	,	PUNCT
gjear-961	62	41	a	a	DET
gjear-961	62	42	50:50	50:50	NUM
gjear-961	62	43	mixture	mixture	NOUN
gjear-961	62	44	of	of	ADP
gjear-961	62	45	acetonitrile	acetonitrile	NOUN
gjear-961	62	46	and	and	CCONJ
gjear-961	62	47	5	5	NUM
gjear-961	62	48	mm	mm	NOUN
gjear-961	62	49	ammonium	ammonium	NOUN
gjear-961	62	50	acetate	acetate	NOUN
gjear-961	62	51	(	(	PUNCT
gjear-961	62	52	ph	ph	PROPN
gjear-961	62	53	8)	8)	NUM
gjear-961	62	54	,	,	PUNCT
gjear-961	62	55	was	be	AUX
gjear-961	62	56	delivered	deliver	VERB
gjear-961	62	57	at	at	ADP
gjear-961	62	58	0.25	0.25	NUM
gjear-961	62	59	ml	ml	NOUN
gjear-961	62	60	/	/	SYM
gjear-961	62	61	min	min	NOUN
gjear-961	62	62	and	and	CCONJ
gjear-961	62	63	samples	sample	NOUN
gjear-961	62	64	were	be	AUX
gjear-961	62	65	detected	detect	VERB
gjear-961	62	66	at	at	ADP
gjear-961	62	67	a	a	DET
gjear-961	62	68	wavelength	wavelength	NOUN
gjear-961	62	69	of	of	ADP
gjear-961	62	70	255	255	NUM
gjear-961	62	71	nm	nm	NOUN
gjear-961	62	72	.	.	PUNCT
gjear-961	63	1	this	this	DET
gjear-961	63	2	mobile	mobile	ADJ
gjear-961	63	3	phase	phase	NOUN
gjear-961	63	4	mixture	mixture	NOUN
gjear-961	63	5	brings	bring	VERB
gjear-961	63	6	back	back	ADV
gjear-961	63	7	an	an	DET
gjear-961	63	8	exemplary	exemplary	ADJ
gjear-961	63	9	chromatogram	chromatogram	NOUN
gjear-961	63	10	of	of	ADP
gjear-961	63	11	chondroitin	chondroitin	NOUN
gjear-961	63	12	,	,	PUNCT
gjear-961	63	13	which	which	PRON
gjear-961	63	14	is	be	AUX
gjear-961	63	15	an	an	DET
gjear-961	63	16	excellent	excellent	ADJ
gjear-961	63	17	and	and	CCONJ
gjear-961	63	18	symmetrical	symmetrical	ADJ
gjear-961	63	19	peak	peak	NOUN
gjear-961	63	20	.	.	PUNCT
gjear-961	64	1	global	global	ADJ
gjear-961	64	2	research	research	PROPN
gjear-961	64	3	journal	journal	PROPN
gjear-961	64	4	of	of	ADP
gjear-961	64	5	management	management	NOUN
gjear-961	64	6	and	and	CCONJ
gjear-961	64	7	social	social	ADJ
gjear-961	64	8	sciences	science	NOUN
gjear-961	64	9	(	(	PUNCT
gjear-961	64	10	grjmss	grjmss	PROPN
gjear-961	64	11	)	)	PUNCT
gjear-961	64	12	vol	vol	NOUN
gjear-961	64	13	.	.	PROPN
gjear-961	64	14	13	13	NUM
gjear-961	64	15	(	(	PUNCT
gjear-961	64	16	12	12	NUM
gjear-961	64	17	)	)	PUNCT
gjear-961	64	18	pg	pg	NOUN
gjear-961	64	19	.	.	PUNCT
gjear-961	65	1	21	21	NUM
gjear-961	65	2	figure	figure	NOUN
gjear-961	65	3	1	1	NUM
gjear-961	65	4	.	.	PUNCT
gjear-961	65	5	chondroitin	chondroitin	PROPN
gjear-961	65	6	chromatogram	chromatogram	PROPN
gjear-961	65	7	(	(	PUNCT
gjear-961	65	8	mobile	mobile	ADJ
gjear-961	65	9	phase	phase	NOUN
gjear-961	65	10	:	:	PUNCT
gjear-961	65	11	acetonitrile	acetonitrile	NOUN
gjear-961	65	12	:	:	PUNCT
gjear-961	65	13	5	5	NUM
gjear-961	65	14	mm	mm	NOUN
gjear-961	65	15	ammonium	ammonium	NOUN
gjear-961	65	16	acetate	acetate	NOUN
gjear-961	65	17	(	(	PUNCT
gjear-961	65	18	ph	ph	PROPN
gjear-961	65	19	8)	8)	NUM
gjear-961	65	20	(	(	PUNCT
gjear-961	65	21	50:50	50:50	NUM
gjear-961	65	22	)	)	PUNCT
gjear-961	65	23	)	)	PUNCT
gjear-961	65	24	figure	figure	NOUN
gjear-961	65	25	2	2	NUM
gjear-961	65	26	.	.	PUNCT
gjear-961	65	27	glucosamine	glucosamine	NOUN
gjear-961	65	28	chromatogram	chromatogram	PROPN
gjear-961	65	29	under	under	ADP
gjear-961	65	30	optimal	optimal	ADJ
gjear-961	65	31	conditions	condition	NOUN
gjear-961	65	32	3.1.2	3.1.2	NUM
gjear-961	65	33	.	.	PUNCT
gjear-961	65	34	glucosamine	glucosamine	NOUN
gjear-961	65	35	determination	determination	NOUN
gjear-961	65	36	the	the	DET
gjear-961	65	37	following	follow	VERB
gjear-961	65	38	factors	factor	NOUN
gjear-961	65	39	were	be	AUX
gjear-961	65	40	investigated	investigate	VERB
gjear-961	65	41	:	:	PUNCT
gjear-961	65	42	reaction	reaction	NOUN
gjear-961	65	43	temperature	temperature	NOUN
gjear-961	65	44	of	of	ADP
gjear-961	65	45	derivatization	derivatization	NOUN
gjear-961	65	46	,	,	PUNCT
gjear-961	65	47	quantitative	quantitative	ADJ
gjear-961	65	48	wavelength	wavelength	NOUN
gjear-961	65	49	,	,	PUNCT
gjear-961	65	50	and	and	CCONJ
gjear-961	65	51	mobile	mobile	ADJ
gjear-961	65	52	phase	phase	NOUN
gjear-961	65	53	ratio	ratio	NOUN
gjear-961	65	54	,	,	PUNCT
gjear-961	65	55	respectively	respectively	ADV
gjear-961	65	56	.	.	PUNCT
gjear-961	66	1	depending	depend	VERB
gjear-961	66	2	on	on	ADP
gjear-961	66	3	the	the	DET
gjear-961	66	4	stability	stability	NOUN
gjear-961	66	5	of	of	ADP
gjear-961	66	6	glucosamine	glucosamine	NOUN
gjear-961	66	7	-	-	PUNCT
gjear-961	66	8	fmoc	fmoc	NOUN
gjear-961	66	9	-	-	PUNCT
gjear-961	66	10	cl	cl	NOUN
gjear-961	66	11	over	over	ADP
gjear-961	66	12	time	time	NOUN
gjear-961	66	13	and	and	CCONJ
gjear-961	66	14	a	a	DET
gjear-961	66	15	result	result	NOUN
gjear-961	66	16	shown	show	VERB
gjear-961	66	17	on	on	ADP
gjear-961	66	18	the	the	DET
gjear-961	66	19	chromatogram	chromatogram	NOUN
gjear-961	66	20	,	,	PUNCT
gjear-961	66	21	reaction	reaction	NOUN
gjear-961	66	22	temperature	temperature	NOUN
gjear-961	66	23	has	have	AUX
gjear-961	66	24	been	be	AUX
gjear-961	66	25	chosen	choose	VERB
gjear-961	66	26	.	.	PUNCT
gjear-961	67	1	the	the	DET
gjear-961	67	2	maximum	maximum	ADJ
gjear-961	67	3	absorption	absorption	NOUN
gjear-961	67	4	peak	peak	NOUN
gjear-961	67	5	of	of	ADP
gjear-961	67	6	the	the	DET
gjear-961	67	7	derived	derive	VERB
gjear-961	67	8	glucosamine	glucosamine	NOUN
gjear-961	67	9	is	be	AUX
gjear-961	67	10	259	259	NUM
gjear-961	67	11	nm	nm	NOUN
gjear-961	67	12	;	;	PUNCT
gjear-961	67	13	conducting	conduct	VERB
gjear-961	67	14	a	a	DET
gjear-961	67	15	survey	survey	NOUN
gjear-961	67	16	,	,	PUNCT
gjear-961	67	17	at	at	ADP
gjear-961	67	18	255	255	NUM
gjear-961	67	19	nm	nm	NOUN
gjear-961	67	20	,	,	PUNCT
gjear-961	67	21	the	the	DET
gjear-961	67	22	derived	derive	VERB
gjear-961	67	23	peak	peak	NOUN
gjear-961	67	24	signal	signal	NOUN
gjear-961	67	25	is	be	AUX
gjear-961	67	26	good	good	ADJ
gjear-961	67	27	,	,	PUNCT
gjear-961	67	28	with	with	ADP
gjear-961	67	29	little	little	ADJ
gjear-961	67	30	background	background	NOUN
gjear-961	67	31	noise	noise	NOUN
gjear-961	67	32	,	,	PUNCT
gjear-961	67	33	so	so	CCONJ
gjear-961	67	34	the	the	DET
gjear-961	67	35	quantitation	quantitation	NOUN
gjear-961	67	36	wavelength	wavelength	NOUN
gjear-961	67	37	is	be	AUX
gjear-961	67	38	255	255	NUM
gjear-961	67	39	nm	nm	NOUN
gjear-961	67	40	.	.	PUNCT
gjear-961	68	1	the	the	DET
gjear-961	68	2	chosen	choose	VERB
gjear-961	68	3	mobile	mobile	ADJ
gjear-961	68	4	phase	phase	NOUN
gjear-961	68	5	was	be	AUX
gjear-961	68	6	also	also	ADV
gjear-961	68	7	accepted	accept	VERB
gjear-961	68	8	as	as	ADP
gjear-961	68	9	a	a	DET
gjear-961	68	10	reasonable	reasonable	ADJ
gjear-961	68	11	and	and	CCONJ
gjear-961	68	12	symmetrical	symmetrical	ADJ
gjear-961	68	13	peak	peak	NOUN
gjear-961	68	14	requirement	requirement	NOUN
gjear-961	68	15	.	.	PUNCT
gjear-961	69	1	the	the	DET
gjear-961	69	2	optimal	optimal	ADJ
gjear-961	69	3	chromatographic	chromatographic	ADJ
gjear-961	69	4	conditions	condition	NOUN
gjear-961	69	5	for	for	ADP
gjear-961	69	6	glucosamine	glucosamine	NOUN
gjear-961	69	7	were	be	AUX
gjear-961	69	8	selected	select	VERB
gjear-961	69	9	based	base	VERB
gjear-961	69	10	on	on	ADP
gjear-961	69	11	the	the	DET
gjear-961	69	12	research	research	NOUN
gjear-961	69	13	of	of	ADP
gjear-961	69	14	huang	huang	PROPN
gjear-961	69	15	(	(	PUNCT
gjear-961	69	16	2006	2006	NUM
gjear-961	69	17	)	)	PUNCT
gjear-961	69	18	,	,	PUNCT
gjear-961	69	19	the	the	DET
gjear-961	69	20	investigation	investigation	NOUN
gjear-961	69	21	factor	factor	NOUN
gjear-961	69	22	of	of	ADP
gjear-961	69	23	derivatization	derivatization	NOUN
gjear-961	69	24	and	and	CCONJ
gjear-961	69	25	quantification	quantification	NOUN
gjear-961	69	26	has	have	AUX
gjear-961	69	27	been	be	AUX
gjear-961	69	28	chosen	choose	VERB
gjear-961	69	29	.	.	PUNCT
gjear-961	70	1	the	the	DET
gjear-961	70	2	results	result	NOUN
gjear-961	70	3	showed	show	VERB
gjear-961	70	4	the	the	DET
gjear-961	70	5	most	most	ADV
gjear-961	70	6	potential	potential	ADJ
gjear-961	70	7	condition	condition	NOUN
gjear-961	70	8	is	be	AUX
gjear-961	70	9	using	use	VERB
gjear-961	70	10	the	the	DET
gjear-961	70	11	indirect	indirect	ADJ
gjear-961	70	12	method	method	NOUN
gjear-961	70	13	of	of	ADP
gjear-961	70	14	pre	pre	ADJ
gjear-961	70	15	-	-	ADJ
gjear-961	70	16	column	column	ADJ
gjear-961	70	17	derivatization	derivatization	NOUN
gjear-961	70	18	by	by	ADP
gjear-961	70	19	hydrolysis	hydrolysis	NOUN
gjear-961	70	20	with	with	ADP
gjear-961	70	21	alkaline	alkaline	ADJ
gjear-961	70	22	agents	agent	NOUN
gjear-961	70	23	and	and	CCONJ
gjear-961	70	24	fmoccl	fmoccl	ADJ
gjear-961	70	25	reagent	reagent	NOUN
gjear-961	70	26	at	at	ADP
gjear-961	70	27	the	the	DET
gjear-961	70	28	reaction	reaction	NOUN
gjear-961	70	29	temperature	temperature	NOUN
gjear-961	70	30	of	of	ADP
gjear-961	70	31	50	50	NUM
gjear-961	70	32	°	°	NOUN
gjear-961	70	33	c	c	NOUN
gjear-961	70	34	,	,	PUNCT
gjear-961	70	35	quantified	quantify	VERB
gjear-961	70	36	on	on	ADP
gjear-961	70	37	the	the	DET
gjear-961	70	38	tuv	tuv	PROPN
gjear-961	70	39	probe	probe	PROPN
gjear-961	70	40	uplc	uplc	PROPN
gjear-961	70	41	system	system	NOUN
gjear-961	70	42	with	with	ADP
gjear-961	70	43	the	the	DET
gjear-961	70	44	acquity	acquity	NOUN
gjear-961	70	45	uplc	uplc	PUNCT
gjear-961	70	46	beh	beh	PROPN
gjear-961	70	47	c18	c18	PROPN
gjear-961	70	48	column	column	NOUN
gjear-961	70	49	(	(	PUNCT
gjear-961	70	50	2.1	2.1	NUM
gjear-961	70	51	×	×	NOUN
gjear-961	70	52	100	100	NUM
gjear-961	70	53	mm	mm	NOUN
gjear-961	70	54	,	,	PUNCT
gjear-961	70	55	1.7	1.7	NUM
gjear-961	70	56	μm	μm	NUM
gjear-961	70	57	)	)	PUNCT
gjear-961	70	58	;	;	PUNCT
gjear-961	70	59	detection	detection	NOUN
gjear-961	70	60	wavelength	wavelength	NOUN
gjear-961	70	61	255	255	NUM
gjear-961	70	62	nm	nm	NOUN
gjear-961	70	63	;	;	PUNCT
gjear-961	70	64	flow	flow	NOUN
gjear-961	70	65	rate	rate	NOUN
gjear-961	70	66	0.25	0.25	NUM
gjear-961	70	67	ml	ml	NOUN
gjear-961	70	68	/	/	SYM
gjear-961	70	69	min	min	NOUN
gjear-961	70	70	;	;	PUNCT
gjear-961	70	71	sample	sample	NOUN
gjear-961	70	72	injection	injection	NOUN
gjear-961	70	73	volume	volume	NOUN
gjear-961	70	74	10	10	NUM
gjear-961	70	75	μl	μl	NOUN
gjear-961	70	76	.	.	PUNCT
gjear-961	71	1	mobile	mobile	ADJ
gjear-961	71	2	phase	phase	NOUN
gjear-961	71	3	a	a	PRON
gjear-961	71	4	is	be	AUX
gjear-961	71	5	acetonitrile	acetonitrile	ADJ
gjear-961	71	6	;	;	PUNCT
gjear-961	71	7	mobile	mobile	ADJ
gjear-961	71	8	phase	phase	NOUN
gjear-961	71	9	b	b	NOUN
gjear-961	71	10	is	be	AUX
gjear-961	71	11	water	water	NOUN
gjear-961	71	12	.	.	PUNCT
gjear-961	72	1	the	the	DET
gjear-961	72	2	mobile	mobile	ADJ
gjear-961	72	3	phase	phase	NOUN
gjear-961	72	4	ratio	ratio	NOUN
gjear-961	72	5	was	be	AUX
gjear-961	72	6	adjusted	adjust	VERB
gjear-961	72	7	according	accord	VERB
gjear-961	72	8	to	to	ADP
gjear-961	72	9	the	the	DET
gjear-961	72	10	gradient	gradient	NOUN
gjear-961	72	11	elution	elution	NOUN
gjear-961	72	12	program	program	NOUN
gjear-961	73	1	[	[	X
gjear-961	73	2	time	time	NOUN
gjear-961	73	3	(	(	PUNCT
gjear-961	73	4	minutes)/%a	minutes)/%a	X
gjear-961	73	5	]	]	PUNCT
gjear-961	73	6	as	as	SCONJ
gjear-961	73	7	follows	follow	VERB
gjear-961	73	8	0	0	NUM
gjear-961	73	9	-	-	SYM
gjear-961	73	10	2.5/35	2.5/35	NUM
gjear-961	73	11	,	,	PUNCT
gjear-961	73	12	2.5	2.5	NUM
gjear-961	73	13	-	-	PUNCT
gjear-961	73	14	4/60	4/60	NUM
gjear-961	73	15	.	.	PUNCT
gjear-961	74	1	global	global	ADJ
gjear-961	74	2	research	research	PROPN
gjear-961	74	3	journal	journal	PROPN
gjear-961	74	4	of	of	ADP
gjear-961	74	5	management	management	NOUN
gjear-961	74	6	and	and	CCONJ
gjear-961	74	7	social	social	ADJ
gjear-961	74	8	sciences	science	NOUN
gjear-961	74	9	(	(	PUNCT
gjear-961	74	10	grjmss	grjmss	PROPN
gjear-961	74	11	)	)	PUNCT
gjear-961	74	12	vol	vol	NOUN
gjear-961	74	13	.	.	PROPN
gjear-961	74	14	13	13	NUM
gjear-961	74	15	(	(	PUNCT
gjear-961	74	16	12	12	NUM
gjear-961	74	17	)	)	PUNCT
gjear-961	74	18	pg	pg	NOUN
gjear-961	74	19	.	.	PUNCT
gjear-961	75	1	22	22	NUM
gjear-961	75	2	figure	figure	NOUN
gjear-961	75	3	3	3	NUM
gjear-961	75	4	.	.	X
gjear-961	75	5	chromatogram	chromatogram	PROPN
gjear-961	75	6	(	(	PUNCT
gjear-961	75	7	1	1	NUM
gjear-961	75	8	)	)	PUNCT
gjear-961	75	9	reactive	reactive	ADJ
gjear-961	75	10	solvent	solvent	NOUN
gjear-961	75	11	,	,	PUNCT
gjear-961	75	12	(	(	PUNCT
gjear-961	75	13	2	2	X
gjear-961	75	14	)	)	PUNCT
gjear-961	75	15	unreacted	unreacted	ADJ
gjear-961	75	16	glucosamine	glucosamine	NOUN
gjear-961	75	17	sample	sample	NOUN
gjear-961	75	18	(	(	PUNCT
gjear-961	75	19	3	3	NUM
gjear-961	75	20	)	)	PUNCT
gjear-961	75	21	sample	sample	NOUN
gjear-961	75	22	solvent	solvent	NOUN
gjear-961	75	23	,	,	PUNCT
gjear-961	75	24	(	(	PUNCT
gjear-961	75	25	4	4	X
gjear-961	75	26	)	)	PUNCT
gjear-961	75	27	mobile	mobile	ADJ
gjear-961	75	28	phase	phase	NOUN
gjear-961	75	29	sample	sample	NOUN
gjear-961	75	30	3.2	3.2	NUM
gjear-961	75	31	.	.	PUNCT
gjear-961	76	1	system	system	NOUN
gjear-961	76	2	suitability	suitability	NOUN
gjear-961	76	3	testing	testing	NOUN
gjear-961	76	4	system	system	NOUN
gjear-961	76	5	suitability	suitability	NOUN
gjear-961	76	6	testing	testing	NOUN
gjear-961	76	7	was	be	AUX
gjear-961	76	8	assessed	assess	VERB
gjear-961	76	9	by	by	ADP
gjear-961	76	10	analyzing	analyze	VERB
gjear-961	76	11	six	six	NUM
gjear-961	76	12	replicates	replicate	NOUN
gjear-961	76	13	of	of	ADP
gjear-961	76	14	glucosamine	glucosamine	NOUN
gjear-961	76	15	fmoc	fmoc	NOUN
gjear-961	76	16	-	-	PUNCT
gjear-961	76	17	cl	cl	NOUN
gjear-961	76	18	standard	standard	NOUN
gjear-961	76	19	at	at	ADP
gjear-961	76	20	25	25	NUM
gjear-961	76	21	g	g	NOUN
gjear-961	76	22	/	/	SYM
gjear-961	76	23	ml	ml	NOUN
gjear-961	76	24	and	and	CCONJ
gjear-961	76	25	chondroitin	chondroitin	PROPN
gjear-961	76	26	standard	standard	NOUN
gjear-961	76	27	at	at	ADP
gjear-961	76	28	300	300	NUM
gjear-961	76	29	µg	µg	NOUN
gjear-961	76	30	/	/	SYM
gjear-961	76	31	ml	ml	NOUN
gjear-961	76	32	.	.	PUNCT
gjear-961	77	1	the	the	DET
gjear-961	77	2	results	result	NOUN
gjear-961	77	3	in	in	ADP
gjear-961	77	4	table	table	NOUN
gjear-961	77	5	1	1	NUM
gjear-961	77	6	show	show	VERB
gjear-961	77	7	that	that	SCONJ
gjear-961	77	8	the	the	DET
gjear-961	77	9	rsd%	rsd%	NOUN
gjear-961	77	10	of	of	ADP
gjear-961	77	11	the	the	DET
gjear-961	77	12	retention	retention	NOUN
gjear-961	77	13	time	time	NOUN
gjear-961	77	14	and	and	CCONJ
gjear-961	77	15	the	the	DET
gjear-961	77	16	peak	peak	NOUN
gjear-961	77	17	area	area	NOUN
gjear-961	77	18	are	be	AUX
gjear-961	77	19	both	both	ADV
gjear-961	77	20	less	less	ADJ
gjear-961	77	21	than	than	ADP
gjear-961	77	22	2	2	NUM
gjear-961	77	23	%	%	NOUN
gjear-961	77	24	.	.	PUNCT
gjear-961	78	1	the	the	DET
gjear-961	78	2	chromatographic	chromatographic	ADJ
gjear-961	78	3	parameters	parameter	NOUN
gjear-961	78	4	are	be	AUX
gjear-961	78	5	within	within	ADP
gjear-961	78	6	the	the	DET
gjear-961	78	7	acceptable	acceptable	ADJ
gjear-961	78	8	range	range	NOUN
gjear-961	78	9	:	:	PUNCT
gjear-961	78	10	from	from	ADP
gjear-961	78	11	0.8	0.8	NUM
gjear-961	78	12	to	to	ADP
gjear-961	78	13	1.5	1.5	NUM
gjear-961	78	14	for	for	ADP
gjear-961	78	15	asymmetry	asymmetry	NOUN
gjear-961	78	16	factor	factor	NOUN
gjear-961	78	17	(	(	PUNCT
gjear-961	78	18	as	as	ADP
gjear-961	78	19	)	)	PUNCT
gjear-961	78	20	and	and	CCONJ
gjear-961	78	21	higher	high	ADJ
gjear-961	78	22	than	than	ADP
gjear-961	78	23	1.5	1.5	NUM
gjear-961	78	24	for	for	ADP
gjear-961	78	25	resolution	resolution	NOUN
gjear-961	78	26	(	(	PUNCT
gjear-961	78	27	rs	rs	NOUN
gjear-961	78	28	)	)	PUNCT
gjear-961	78	29	.	.	PUNCT
gjear-961	79	1	consequently	consequently	ADV
gjear-961	79	2	,	,	PUNCT
gjear-961	79	3	instrumentation	instrumentation	NOUN
gjear-961	79	4	quality	quality	NOUN
gjear-961	79	5	is	be	AUX
gjear-961	79	6	acceptable	acceptable	ADJ
gjear-961	79	7	for	for	ADP
gjear-961	79	8	research	research	NOUN
gjear-961	79	9	.	.	PUNCT
gjear-961	80	1	table	table	NOUN
gjear-961	80	2	1	1	NUM
gjear-961	80	3	.	.	PUNCT
gjear-961	81	1	system	system	NOUN
gjear-961	81	2	suitability	suitability	NOUN
gjear-961	81	3	testing	test	VERB
gjear-961	81	4	tr	tr	NOUN
gjear-961	81	5	s	s	NOUN
gjear-961	81	6	as	as	ADP
gjear-961	81	7	rs	rs	NOUN
gjear-961	81	8	k	k	NOUN
gjear-961	81	9	’	'	PUNCT
gjear-961	81	10	glucosamine	glucosamine	NOUN
gjear-961	81	11	mean	mean	VERB
gjear-961	81	12	2.24	2.24	NUM
gjear-961	81	13	17437.5	17437.5	NUM
gjear-961	81	14	1.45	1.45	NUM
gjear-961	81	15	3.8	3.8	NUM
gjear-961	81	16	1.49	1.49	NUM
gjear-961	81	17	rsd%	rsd%	NOUN
gjear-961	81	18	0.4	0.4	NUM
gjear-961	81	19	0.21	0.21	NUM
gjear-961	81	20	1.23	1.23	NUM
gjear-961	81	21	1.2	1.2	NUM
gjear-961	81	22	0.86	0.86	NUM
gjear-961	81	23	chondroitin	chondroitin	NOUN
gjear-961	81	24	mean	mean	NOUN
gjear-961	81	25	0.69	0.69	NUM
gjear-961	81	26	1400.2	1400.2	NUM
gjear-961	81	27	1.39	1.39	NUM
gjear-961	81	28	2.5	2.5	NUM
gjear-961	81	29	0.75	0.75	NUM
gjear-961	81	30	rsd%	rsd%	NOUN
gjear-961	81	31	1.58	1.58	NUM
gjear-961	81	32	0.32	0.32	NUM
gjear-961	81	33	1.45	1.45	NUM
gjear-961	81	34	0.87	0.87	NUM
gjear-961	81	35	0.67	0.67	NUM
gjear-961	81	36	3.3	3.3	NUM
gjear-961	81	37	.	.	PUNCT
gjear-961	82	1	selectivity	selectivity	NOUN
gjear-961	82	2	figure	figure	NOUN
gjear-961	82	3	3	3	NUM
gjear-961	82	4	-	-	SYM
gjear-961	82	5	5	5	NUM
gjear-961	82	6	shows	show	VERB
gjear-961	82	7	that	that	SCONJ
gjear-961	82	8	sample	sample	NOUN
gjear-961	82	9	chromatograms	chromatogram	NOUN
gjear-961	82	10	had	have	VERB
gjear-961	82	11	peaks	peak	NOUN
gjear-961	82	12	of	of	ADP
gjear-961	82	13	glucosamine	glucosamine	NOUN
gjear-961	82	14	-	-	PUNCT
gjear-961	82	15	fmoc	fmoc	NOUN
gjear-961	82	16	-	-	PUNCT
gjear-961	82	17	cl	cl	NOUN
gjear-961	82	18	and	and	CCONJ
gjear-961	82	19	chondroitin	chondroitin	NOUN
gjear-961	82	20	with	with	ADP
gjear-961	82	21	retention	retention	NOUN
gjear-961	82	22	times	time	NOUN
gjear-961	82	23	equivalent	equivalent	ADJ
gjear-961	82	24	to	to	ADP
gjear-961	82	25	the	the	DET
gjear-961	82	26	prominent	prominent	ADJ
gjear-961	82	27	peaks	peak	NOUN
gjear-961	82	28	in	in	ADP
gjear-961	82	29	the	the	DET
gjear-961	82	30	standard	standard	ADJ
gjear-961	82	31	chromatograms	chromatogram	NOUN
gjear-961	82	32	.	.	PUNCT
gjear-961	83	1	no	no	DET
gjear-961	83	2	significant	significant	ADJ
gjear-961	83	3	interference	interference	NOUN
gjear-961	83	4	from	from	ADP
gjear-961	83	5	mobile	mobile	ADJ
gjear-961	83	6	phase	phase	NOUN
gjear-961	83	7	,	,	PUNCT
gjear-961	83	8	solvent	solvent	NOUN
gjear-961	83	9	,	,	PUNCT
gjear-961	83	10	underivatized	underivatize	VERB
gjear-961	83	11	glucosamine	glucosamine	NOUN
gjear-961	83	12	,	,	PUNCT
gjear-961	83	13	and	and	CCONJ
gjear-961	83	14	reaction	reaction	NOUN
gjear-961	83	15	solvent	solvent	NOUN
gjear-961	83	16	was	be	AUX
gjear-961	83	17	observed	observe	VERB
gjear-961	83	18	at	at	ADP
gjear-961	83	19	the	the	DET
gjear-961	83	20	retention	retention	NOUN
gjear-961	83	21	time	time	NOUN
gjear-961	83	22	of	of	ADP
gjear-961	83	23	analytes	analyte	NOUN
gjear-961	83	24	.	.	PUNCT
gjear-961	84	1	the	the	DET
gjear-961	84	2	procedure	procedure	NOUN
gjear-961	84	3	for	for	ADP
gjear-961	84	4	quantifying	quantify	VERB
gjear-961	84	5	glucosamine	glucosamine	NOUN
gjear-961	84	6	and	and	CCONJ
gjear-961	84	7	chondroitin	chondroitin	NOUN
gjear-961	84	8	meets	meet	VERB
gjear-961	84	9	the	the	DET
gjear-961	84	10	requirements	requirement	NOUN
gjear-961	84	11	for	for	ADP
gjear-961	84	12	selectivity	selectivity	NOUN
gjear-961	84	13	.	.	PUNCT
gjear-961	85	1	global	global	ADJ
gjear-961	85	2	research	research	PROPN
gjear-961	85	3	journal	journal	PROPN
gjear-961	85	4	of	of	ADP
gjear-961	85	5	management	management	NOUN
gjear-961	85	6	and	and	CCONJ
gjear-961	85	7	social	social	ADJ
gjear-961	85	8	sciences	science	NOUN
gjear-961	85	9	(	(	PUNCT
gjear-961	85	10	grjmss	grjmss	PROPN
gjear-961	85	11	)	)	PUNCT
gjear-961	85	12	vol	vol	NOUN
gjear-961	85	13	.	.	PROPN
gjear-961	85	14	13	13	NUM
gjear-961	85	15	(	(	PUNCT
gjear-961	85	16	12	12	NUM
gjear-961	85	17	)	)	PUNCT
gjear-961	85	18	pg	pg	NOUN
gjear-961	85	19	.	.	PUNCT
gjear-961	86	1	23	23	NUM
gjear-961	86	2	figure	figure	NOUN
gjear-961	86	3	4	4	NUM
gjear-961	86	4	.	.	X
gjear-961	86	5	chromatogram	chromatogram	PROPN
gjear-961	86	6	of	of	ADP
gjear-961	86	7	glucosamine	glucosamine	NOUN
gjear-961	86	8	-	-	PUNCT
gjear-961	86	9	fmoc	fmoc	NOUN
gjear-961	86	10	-	-	PUNCT
gjear-961	86	11	cl	cl	NOUN
gjear-961	86	12	in	in	ADP
gjear-961	86	13	the	the	DET
gjear-961	86	14	standard	standard	ADJ
gjear-961	86	15	sample	sample	NOUN
gjear-961	86	16	(	(	PUNCT
gjear-961	86	17	1	1	NUM
gjear-961	86	18	)	)	PUNCT
gjear-961	86	19	,	,	PUNCT
gjear-961	86	20	testing	test	VERB
gjear-961	86	21	sample	sample	NOUN
gjear-961	86	22	(	(	PUNCT
gjear-961	86	23	2	2	NUM
gjear-961	86	24	)	)	PUNCT
gjear-961	86	25	,	,	PUNCT
gjear-961	86	26	and	and	CCONJ
gjear-961	86	27	spiked	spiked	ADJ
gjear-961	86	28	sample	sample	NOUN
gjear-961	86	29	(	(	PUNCT
gjear-961	86	30	3	3	NUM
gjear-961	86	31	)	)	PUNCT
gjear-961	86	32	figure	figure	NOUN
gjear-961	86	33	5	5	NUM
gjear-961	86	34	.	.	PUNCT
gjear-961	87	1	chromatogram	chromatogram	PROPN
gjear-961	87	2	of	of	ADP
gjear-961	87	3	mobile	mobile	ADJ
gjear-961	87	4	phase	phase	NOUN
gjear-961	87	5	(	(	PUNCT
gjear-961	87	6	1	1	NUM
gjear-961	87	7	)	)	PUNCT
gjear-961	87	8	,	,	PUNCT
gjear-961	87	9	solvent	solvent	NOUN
gjear-961	87	10	(	(	PUNCT
gjear-961	87	11	2	2	NUM
gjear-961	87	12	)	)	PUNCT
gjear-961	87	13	,	,	PUNCT
gjear-961	87	14	testing	test	VERB
gjear-961	87	15	sample	sample	NOUN
gjear-961	87	16	(	(	PUNCT
gjear-961	87	17	3	3	NUM
gjear-961	87	18	)	)	PUNCT
gjear-961	87	19	,	,	PUNCT
gjear-961	87	20	chondroitin	chondroitin	PROPN
gjear-961	87	21	standard	standard	PROPN
gjear-961	87	22	sample	sample	NOUN
gjear-961	87	23	(	(	PUNCT
gjear-961	87	24	4	4	NUM
gjear-961	87	25	)	)	PUNCT
gjear-961	87	26	,	,	PUNCT
gjear-961	87	27	spiked	spiked	ADJ
gjear-961	87	28	sample	sample	NOUN
gjear-961	87	29	(	(	PUNCT
gjear-961	87	30	5	5	NUM
gjear-961	87	31	)	)	PUNCT
gjear-961	87	32	3.4	3.4	NUM
gjear-961	87	33	.	.	PUNCT
gjear-961	88	1	linearity	linearity	VERB
gjear-961	88	2	the	the	DET
gjear-961	88	3	investigation	investigation	NOUN
gjear-961	88	4	of	of	ADP
gjear-961	88	5	linearity	linearity	NOUN
gjear-961	88	6	is	be	AUX
gjear-961	88	7	over	over	ADP
gjear-961	88	8	the	the	DET
gjear-961	88	9	concentration	concentration	NOUN
gjear-961	88	10	range	range	NOUN
gjear-961	88	11	of	of	ADP
gjear-961	88	12	10	10	NUM
gjear-961	88	13	-	-	SYM
gjear-961	88	14	100	100	NUM
gjear-961	88	15	µg	µg	NOUN
gjear-961	88	16	/	/	SYM
gjear-961	88	17	ml	ml	NOUN
gjear-961	88	18	for	for	ADP
gjear-961	88	19	glucosaminefmoc	glucosaminefmoc	NOUN
gjear-961	88	20	-	-	PUNCT
gjear-961	88	21	cl	cl	NOUN
gjear-961	88	22	and	and	CCONJ
gjear-961	88	23	50	50	NUM
gjear-961	88	24	-	-	SYM
gjear-961	88	25	1000	1000	NUM
gjear-961	88	26	µg	µg	NOUN
gjear-961	88	27	/	/	SYM
gjear-961	88	28	ml	ml	NOUN
gjear-961	88	29	for	for	ADP
gjear-961	88	30	chondroitin	chondroitin	NOUN
gjear-961	88	31	.	.	PUNCT
gjear-961	89	1	the	the	DET
gjear-961	89	2	correlation	correlation	NOUN
gjear-961	89	3	coefficients	coefficient	VERB
gjear-961	89	4	during	during	ADP
gjear-961	89	5	the	the	DET
gjear-961	89	6	validation	validation	NOUN
gjear-961	89	7	were	be	AUX
gjear-961	89	8	0.999	0.999	NUM
gjear-961	89	9	and	and	CCONJ
gjear-961	89	10	0.998	0.998	NUM
gjear-961	89	11	,	,	PUNCT
gjear-961	89	12	respectively	respectively	ADV
gjear-961	89	13	.	.	PUNCT
gjear-961	89	14	table	table	NOUN
gjear-961	89	15	2	2	NUM
gjear-961	89	16	.	.	X
gjear-961	89	17	linearity	linearity	NOUN
gjear-961	89	18	of	of	ADP
gjear-961	89	19	glucosamine	glucosamine	NOUN
gjear-961	89	20	-	-	PUNCT
gjear-961	89	21	fmoc	fmoc	NOUN
gjear-961	89	22	-	-	PUNCT
gjear-961	89	23	cl	cl	NOUN
gjear-961	89	24	and	and	CCONJ
gjear-961	89	25	chondroitin	chondroitin	NOUN
gjear-961	89	26	linearity	linearity	PROPN
gjear-961	89	27	range	range	NOUN
gjear-961	89	28	(	(	PUNCT
gjear-961	89	29	µg	µg	NOUN
gjear-961	89	30	/	/	SYM
gjear-961	89	31	ml	ml	NOUN
gjear-961	89	32	)	)	PUNCT
gjear-961	89	33	regression	regression	NOUN
gjear-961	89	34	equations	equation	NOUN
gjear-961	89	35	,	,	PUNCT
gjear-961	89	36	r2	r2	PROPN
gjear-961	89	37	glucosamin	glucosamin	PROPN
gjear-961	89	38	fmoc	fmoc	NOUN
gjear-961	89	39	-	-	PUNCT
gjear-961	89	40	cl	cl	NOUN
gjear-961	89	41	10	10	NUM
gjear-961	89	42	-	-	SYM
gjear-961	89	43	100	100	NUM
gjear-961	89	44	y	y	PROPN
gjear-961	89	45	=	=	SYM
gjear-961	89	46	668.46x	668.46x	PROPN
gjear-961	89	47	,	,	PUNCT
gjear-961	89	48	r2	r2	PROPN
gjear-961	89	49	=	=	PUNCT
gjear-961	89	50	0.999	0.999	NUM
gjear-961	89	51	chondroitin	chondroitin	NOUN
gjear-961	89	52	50	50	NUM
gjear-961	89	53	-	-	SYM
gjear-961	89	54	1000	1000	NUM
gjear-961	89	55	y	y	NOUN
gjear-961	89	56	=	=	SYM
gjear-961	89	57	6.42x	6.42x	PROPN
gjear-961	89	58	,	,	PUNCT
gjear-961	89	59	r2	r2	PROPN
gjear-961	89	60	=	=	PUNCT
gjear-961	89	61	0.998	0.998	NUM
gjear-961	89	62	3.5	3.5	NUM
gjear-961	89	63	.	.	PUNCT
gjear-961	90	1	precision	precision	VERB
gjear-961	90	2	the	the	DET
gjear-961	90	3	method	method	NOUN
gjear-961	90	4	's	's	PART
gjear-961	90	5	precision	precision	NOUN
gjear-961	90	6	was	be	AUX
gjear-961	90	7	verified	verify	VERB
gjear-961	90	8	by	by	ADP
gjear-961	90	9	evaluating	evaluate	VERB
gjear-961	90	10	the	the	DET
gjear-961	90	11	intra	intra	ADJ
gjear-961	90	12	-	-	NOUN
gjear-961	90	13	day	day	NOUN
gjear-961	90	14	and	and	CCONJ
gjear-961	90	15	inter	inter	ADJ
gjear-961	90	16	-	-	ADJ
gjear-961	90	17	day	day	NOUN
gjear-961	90	18	precisions	precision	NOUN
gjear-961	90	19	.	.	PUNCT
gjear-961	91	1	the	the	DET
gjear-961	91	2	relative	relative	ADJ
gjear-961	91	3	standard	standard	ADJ
gjear-961	91	4	deviation	deviation	NOUN
gjear-961	91	5	(	(	PUNCT
gjear-961	91	6	%	%	INTJ
gjear-961	91	7	rsd	rsd	NOUN
gjear-961	91	8	)	)	PUNCT
gjear-961	91	9	was	be	AUX
gjear-961	91	10	selected	select	VERB
gjear-961	91	11	to	to	PART
gjear-961	91	12	measure	measure	VERB
gjear-961	91	13	precision	precision	NOUN
gjear-961	91	14	.	.	PUNCT
gjear-961	92	1	the	the	DET
gjear-961	92	2	intra	intra	ADJ
gjear-961	92	3	-	-	ADJ
gjear-961	92	4	day	day	ADJ
gjear-961	92	5	precision	precision	NOUN
gjear-961	92	6	was	be	AUX
gjear-961	92	7	examined	examine	VERB
gjear-961	92	8	by	by	ADP
gjear-961	92	9	analyzing	analyze	VERB
gjear-961	92	10	six	six	NUM
gjear-961	92	11	samples	sample	NOUN
gjear-961	92	12	in	in	ADP
gjear-961	92	13	a	a	DET
gjear-961	92	14	single	single	ADJ
gjear-961	92	15	day	day	NOUN
gjear-961	92	16	,	,	PUNCT
gjear-961	92	17	while	while	SCONJ
gjear-961	92	18	the	the	DET
gjear-961	92	19	inter	inter	ADJ
gjear-961	92	20	-	-	ADJ
gjear-961	92	21	day	day	ADJ
gjear-961	92	22	precision	precision	NOUN
gjear-961	92	23	was	be	AUX
gjear-961	92	24	determined	determine	VERB
gjear-961	92	25	by	by	ADP
gjear-961	92	26	analyzing	analyze	VERB
gjear-961	92	27	six	six	NUM
gjear-961	92	28	samples	sample	NOUN
gjear-961	92	29	each	each	DET
gjear-961	92	30	day	day	NOUN
gjear-961	92	31	for	for	ADP
gjear-961	92	32	three	three	NUM
gjear-961	92	33	days	day	NOUN
gjear-961	92	34	.	.	PUNCT
gjear-961	93	1	the	the	DET
gjear-961	93	2	precision	precision	NOUN
gjear-961	93	3	results	result	NOUN
gjear-961	93	4	were	be	AUX
gjear-961	93	5	shown	show	VERB
gjear-961	93	6	in	in	ADP
gjear-961	93	7	table	table	NOUN
gjear-961	93	8	3	3	NUM
gjear-961	93	9	,	,	PUNCT
gjear-961	93	10	indicating	indicate	VERB
gjear-961	93	11	that	that	SCONJ
gjear-961	93	12	the	the	DET
gjear-961	93	13	overall	overall	ADJ
gjear-961	93	14	intraand	intraand	X
gjear-961	93	15	inter	inter	ADJ
gjear-961	93	16	-	-	ADJ
gjear-961	93	17	day	day	ADJ
gjear-961	93	18	variations	variation	NOUN
gjear-961	93	19	(	(	PUNCT
gjear-961	93	20	%	%	INTJ
gjear-961	93	21	rsd	rsd	NOUN
gjear-961	93	22	)	)	PUNCT
gjear-961	93	23	were	be	AUX
gjear-961	93	24	less	less	ADJ
gjear-961	93	25	than	than	ADP
gjear-961	93	26	2	2	NUM
gjear-961	93	27	%	%	NOUN
gjear-961	93	28	(	(	PUNCT
gjear-961	93	29	1.50	1.50	NUM
gjear-961	93	30	%	%	NOUN
gjear-961	93	31	and	and	CCONJ
gjear-961	93	32	0,79	0,79	NUM
gjear-961	93	33	%	%	NOUN
gjear-961	93	34	,	,	PUNCT
gjear-961	93	35	respectively	respectively	ADV
gjear-961	93	36	)	)	PUNCT
gjear-961	93	37	.	.	PUNCT
gjear-961	94	1	table	table	NOUN
gjear-961	94	2	3	3	NUM
gjear-961	94	3	.	.	PUNCT
gjear-961	95	1	intra	intra	ADJ
gjear-961	95	2	-	-	NOUN
gjear-961	95	3	day	day	NOUN
gjear-961	95	4	and	and	CCONJ
gjear-961	95	5	inter	inter	ADJ
gjear-961	95	6	-	-	ADJ
gjear-961	95	7	day	day	ADJ
gjear-961	95	8	precision	precision	NOUN
gjear-961	95	9	of	of	ADP
gjear-961	95	10	glucosaminefmoc	glucosaminefmoc	NOUN
gjear-961	95	11	-	-	PUNCT
gjear-961	95	12	cl	cl	NOUN
gjear-961	95	13	(	(	PUNCT
gjear-961	95	14	n	n	NOUN
gjear-961	95	15	=	=	SYM
gjear-961	95	16	6	6	NUM
gjear-961	95	17	)	)	PUNCT
gjear-961	95	18	intra	intra	ADJ
gjear-961	95	19	-	-	ADJ
gjear-961	95	20	day	day	ADJ
gjear-961	95	21	inter	inter	ADJ
gjear-961	95	22	-	-	ADJ
gjear-961	95	23	day	day	ADJ
gjear-961	95	24	sample	sample	NOUN
gjear-961	95	25	peak	peak	NOUN
gjear-961	95	26	area	area	NOUN
gjear-961	95	27	(	(	PUNCT
gjear-961	95	28	mau.s	mau.s	PROPN
gjear-961	95	29	)	)	PUNCT
gjear-961	95	30	content	content	NOUN
gjear-961	95	31	(	(	PUNCT
gjear-961	95	32	mg	mg	NOUN
gjear-961	95	33	)	)	PUNCT
gjear-961	95	34	peak	peak	NOUN
gjear-961	95	35	area	area	NOUN
gjear-961	95	36	(	(	PUNCT
gjear-961	95	37	mau.s	mau.s	PROPN
gjear-961	95	38	)	)	PUNCT
gjear-961	95	39	content	content	NOUN
gjear-961	95	40	(	(	PUNCT
gjear-961	95	41	mg	mg	NOUN
gjear-961	95	42	)	)	PUNCT
gjear-961	95	43	day	day	NOUN
gjear-961	95	44	1	1	NUM
gjear-961	95	45	day	day	NOUN
gjear-961	95	46	2	2	NUM
gjear-961	95	47	day	day	NOUN
gjear-961	95	48	3	3	NUM
gjear-961	95	49	day	day	NOUN
gjear-961	95	50	1	1	NUM
gjear-961	95	51	day	day	NOUN
gjear-961	95	52	2	2	NUM
gjear-961	95	53	day	day	NOUN
gjear-961	95	54	3	3	NUM
gjear-961	95	55	1	1	NUM
gjear-961	95	56	11948	11948	NUM
gjear-961	95	57	491.653	491.653	NUM
gjear-961	95	58	11948	11948	NUM
gjear-961	95	59	11651	11651	NUM
gjear-961	95	60	11472	11472	NUM
gjear-961	96	1	491.65	491.65	NUM
gjear-961	96	2	477.94	477.94	NUM
gjear-961	96	3	469.75	469.75	NUM
gjear-961	96	4	2	2	NUM
gjear-961	96	5	11657	11657	NUM
gjear-961	96	6	478.256	478.256	NUM
gjear-961	96	7	11657	11657	NUM
gjear-961	96	8	11439	11439	NUM
gjear-961	96	9	11401	11401	NUM
gjear-961	96	10	478.25	478.25	NUM
gjear-961	96	11	468.25	468.25	NUM
gjear-961	96	12	466.51	466.51	NUM
gjear-961	96	13	global	global	ADJ
gjear-961	96	14	research	research	NOUN
gjear-961	96	15	journal	journal	PROPN
gjear-961	96	16	of	of	ADP
gjear-961	96	17	management	management	NOUN
gjear-961	96	18	and	and	CCONJ
gjear-961	96	19	social	social	ADJ
gjear-961	96	20	sciences	science	NOUN
gjear-961	96	21	(	(	PUNCT
gjear-961	96	22	grjmss	grjmss	PROPN
gjear-961	96	23	)	)	PUNCT
gjear-961	96	24	vol	vol	NOUN
gjear-961	96	25	.	.	PROPN
gjear-961	96	26	13	13	NUM
gjear-961	96	27	(	(	PUNCT
gjear-961	96	28	12	12	NUM
gjear-961	96	29	)	)	PUNCT
gjear-961	96	30	pg	pg	NOUN
gjear-961	96	31	.	.	NOUN
gjear-961	96	32	24	24	NUM
gjear-961	96	33	3	3	NUM
gjear-961	96	34	11586	11586	NUM
gjear-961	96	35	475.140	475.140	NUM
gjear-961	96	36	11586	11586	NUM
gjear-961	96	37	11526	11526	NUM
gjear-961	96	38	11484	11484	NUM
gjear-961	96	39	475.14	475.14	NUM
gjear-961	96	40	472.24	472.24	NUM
gjear-961	96	41	470.31	470.31	NUM
gjear-961	96	42	4	4	NUM
gjear-961	96	43	11429	11429	NUM
gjear-961	96	44	467.662	467.662	NUM
gjear-961	96	45	11429	11429	NUM
gjear-961	96	46	11541	11541	NUM
gjear-961	96	47	11462	11462	NUM
gjear-961	96	48	467.66	467.66	NUM
gjear-961	96	49	472.93	472.93	NUM
gjear-961	96	50	469.28	469.28	NUM
gjear-961	96	51	5	5	NUM
gjear-961	96	52	11634	11634	NUM
gjear-961	96	53	477.321	477.321	NUM
gjear-961	96	54	11634	11634	NUM
gjear-961	96	55	11554	11554	NUM
gjear-961	96	56	11446	11446	NUM
gjear-961	96	57	477.32	477.32	NUM
gjear-961	96	58	473.52	473.52	NUM
gjear-961	96	59	468.57	468.57	NUM
gjear-961	96	60	6	6	NUM
gjear-961	96	61	11539	11539	NUM
gjear-961	96	62	472.959	472.959	NUM
gjear-961	96	63	11539	11539	NUM
gjear-961	96	64	11521	11521	NUM
gjear-961	96	65	11479	11479	NUM
gjear-961	96	66	472.96	472.96	NUM
gjear-961	96	67	471.99	471.99	NUM
gjear-961	96	68	470.06	470.06	NUM
gjear-961	96	69	mean	mean	NOUN
gjear-961	96	70	11632.17	11632.17	NUM
gjear-961	96	71	477.165	477.165	NUM
gjear-961	96	72	11542.72	11542.72	NUM
gjear-961	96	73	473.01	473.01	NUM
gjear-961	96	74	rsd%	rsd%	NOUN
gjear-961	96	75	1.50	1.50	NUM
gjear-961	96	76	1.685	1.685	NUM
gjear-961	96	77	0.79	0.79	NUM
gjear-961	96	78	0.88	0.88	NUM
gjear-961	96	79	3.6	3.6	NUM
gjear-961	96	80	.	.	PUNCT
gjear-961	97	1	accuracy	accuracy	NOUN
gjear-961	97	2	spiked	spiked	ADJ
gjear-961	97	3	samples	sample	NOUN
gjear-961	97	4	evaluated	evaluate	VERB
gjear-961	97	5	the	the	DET
gjear-961	97	6	accuracy	accuracy	NOUN
gjear-961	97	7	at	at	ADP
gjear-961	97	8	three	three	NUM
gjear-961	97	9	concentrations	concentration	NOUN
gjear-961	97	10	of	of	ADP
gjear-961	97	11	80	80	NUM
gjear-961	97	12	,	,	PUNCT
gjear-961	97	13	100	100	NUM
gjear-961	97	14	,	,	PUNCT
gjear-961	97	15	120	120	NUM
gjear-961	97	16	g	g	NOUN
gjear-961	97	17	/	/	SYM
gjear-961	97	18	ml	ml	NOUN
gjear-961	97	19	for	for	ADP
gjear-961	97	20	glucosamine	glucosamine	NOUN
gjear-961	97	21	-	-	PUNCT
gjear-961	97	22	fmoc	fmoc	NOUN
gjear-961	97	23	-	-	PUNCT
gjear-961	97	24	cl	cl	NOUN
gjear-961	97	25	and	and	CCONJ
gjear-961	97	26	chondroitin	chondroitin	NOUN
gjear-961	97	27	.	.	PUNCT
gjear-961	98	1	each	each	DET
gjear-961	98	2	concentration	concentration	NOUN
gjear-961	98	3	was	be	AUX
gjear-961	98	4	analyzed	analyze	VERB
gjear-961	98	5	in	in	ADP
gjear-961	98	6	duplicate	duplicate	NOUN
gjear-961	98	7	three	three	NUM
gjear-961	98	8	times	time	NOUN
gjear-961	98	9	.	.	PUNCT
gjear-961	99	1	the	the	DET
gjear-961	99	2	mean	mean	ADJ
gjear-961	99	3	recoveries	recovery	NOUN
gjear-961	99	4	of	of	ADP
gjear-961	99	5	glucosaminefmoc	glucosaminefmoc	NOUN
gjear-961	99	6	-	-	PUNCT
gjear-961	99	7	cl	cl	NOUN
gjear-961	99	8	and	and	CCONJ
gjear-961	99	9	chondroitin	chondroitin	NOUN
gjear-961	99	10	are	be	AUX
gjear-961	99	11	101.5	101.5	NUM
gjear-961	99	12	%	%	NOUN
gjear-961	99	13	(	(	PUNCT
gjear-961	99	14	rsd	rsd	NOUN
gjear-961	99	15	=	=	NUM
gjear-961	99	16	1.07	1.07	NUM
gjear-961	99	17	%	%	NOUN
gjear-961	99	18	)	)	PUNCT
gjear-961	99	19	and	and	CCONJ
gjear-961	99	20	100.59	100.59	NUM
gjear-961	99	21	%	%	NOUN
gjear-961	99	22	(	(	PUNCT
gjear-961	99	23	rsd	rsd	NOUN
gjear-961	99	24	=	=	SYM
gjear-961	99	25	0.34	0.34	NUM
gjear-961	99	26	%	%	NOUN
gjear-961	99	27	)	)	PUNCT
gjear-961	99	28	,	,	PUNCT
gjear-961	99	29	respectively	respectively	ADV
gjear-961	99	30	,	,	PUNCT
gjear-961	99	31	which	which	PRON
gjear-961	99	32	meet	meet	VERB
gjear-961	99	33	the	the	DET
gjear-961	99	34	requirement	requirement	NOUN
gjear-961	99	35	of	of	ADP
gjear-961	99	36	ich	ich	NOUN
gjear-961	99	37	guidelines	guideline	NOUN
gjear-961	99	38	.	.	PUNCT
gjear-961	100	1	the	the	DET
gjear-961	100	2	results	result	NOUN
gjear-961	100	3	are	be	AUX
gjear-961	100	4	shown	show	VERB
gjear-961	100	5	in	in	ADP
gjear-961	100	6	table	table	NOUN
gjear-961	100	7	4	4	NUM
gjear-961	100	8	.	.	PUNCT
gjear-961	101	1	the	the	DET
gjear-961	101	2	validation	validation	NOUN
gjear-961	101	3	parameters	parameter	NOUN
gjear-961	101	4	followed	follow	VERB
gjear-961	101	5	the	the	DET
gjear-961	101	6	ich	ich	NOUN
gjear-961	101	7	(	(	PUNCT
gjear-961	101	8	2005	2005	NUM
gjear-961	101	9	)	)	PUNCT
gjear-961	101	10	criteria	criterion	NOUN
gjear-961	101	11	,	,	PUNCT
gjear-961	101	12	making	make	VERB
gjear-961	101	13	this	this	DET
gjear-961	101	14	study	study	NOUN
gjear-961	101	15	potentially	potentially	ADV
gjear-961	101	16	a	a	DET
gjear-961	101	17	widely	widely	ADV
gjear-961	101	18	used	use	VERB
gjear-961	101	19	procedure	procedure	NOUN
gjear-961	101	20	for	for	ADP
gjear-961	101	21	determining	determine	VERB
gjear-961	101	22	glucosamine	glucosamine	NOUN
gjear-961	101	23	and	and	CCONJ
gjear-961	101	24	chondroitin	chondroitin	NOUN
gjear-961	101	25	.	.	PUNCT
gjear-961	102	1	table	table	NOUN
gjear-961	102	2	4	4	NUM
gjear-961	102	3	.	.	PUNCT
gjear-961	103	1	accuracy	accuracy	NOUN
gjear-961	103	2	of	of	ADP
gjear-961	103	3	glucosamine	glucosamine	NOUN
gjear-961	103	4	-	-	PUNCT
gjear-961	103	5	fmoc	fmoc	NOUN
gjear-961	103	6	-	-	PUNCT
gjear-961	103	7	cl	cl	NOUN
gjear-961	103	8	and	and	CCONJ
gjear-961	103	9	chondroitin	chondroitin	NOUN
gjear-961	103	10	(	(	PUNCT
gjear-961	103	11	n	n	NOUN
gjear-961	103	12	=	=	SYM
gjear-961	103	13	6	6	NUM
gjear-961	103	14	)	)	PUNCT
gjear-961	103	15	concentration	concentration	NOUN
gjear-961	103	16	μg	μg	PROPN
gjear-961	103	17	/	/	SYM
gjear-961	103	18	ml	ml	NOUN
gjear-961	103	19	recovery	recovery	NOUN
gjear-961	103	20	(	(	PUNCT
gjear-961	103	21	%	%	INTJ
gjear-961	103	22	)	)	PUNCT
gjear-961	103	23	rsd	rsd	NOUN
gjear-961	103	24	%	%	NOUN
gjear-961	103	25	glucosaminefmoccl	glucosaminefmoccl	NOUN
gjear-961	103	26	80	80	NUM
gjear-961	103	27	100.67	100.67	NUM
gjear-961	103	28	2.7	2.7	NUM
gjear-961	103	29	100	100	NUM
gjear-961	103	30	101.78	101.78	NUM
gjear-961	103	31	0.25	0.25	NUM
gjear-961	103	32	120	120	NUM
gjear-961	103	33	102.05	102.05	NUM
gjear-961	103	34	0.19	0.19	NUM
gjear-961	103	35	chondroitin	chondroitin	NOUN
gjear-961	103	36	80	80	NUM
gjear-961	103	37	100.57	100.57	NUM
gjear-961	103	38	0.32	0.32	NUM
gjear-961	103	39	100	100	NUM
gjear-961	103	40	100.05	100.05	NUM
gjear-961	103	41	0.59	0.59	NUM
gjear-961	103	42	120	120	NUM
gjear-961	103	43	101.15	101.15	NUM
gjear-961	103	44	0.11	0.11	NUM
gjear-961	103	45	3.7	3.7	NUM
gjear-961	103	46	.	.	PUNCT
gjear-961	104	1	application	application	NOUN
gjear-961	104	2	the	the	DET
gjear-961	104	3	quantitative	quantitative	ADJ
gjear-961	104	4	procedure	procedure	NOUN
gjear-961	104	5	after	after	SCONJ
gjear-961	104	6	good	good	ADJ
gjear-961	104	7	validation	validation	NOUN
gjear-961	104	8	was	be	AUX
gjear-961	104	9	applied	apply	VERB
gjear-961	104	10	to	to	ADP
gjear-961	104	11	quantify	quantify	VERB
gjear-961	104	12	glucosamine	glucosamine	NOUN
gjear-961	104	13	and	and	CCONJ
gjear-961	104	14	chondroitin	chondroitin	NOUN
gjear-961	104	15	in	in	ADP
gjear-961	104	16	two	two	NUM
gjear-961	104	17	tablets	tablet	NOUN
gjear-961	104	18	containing	contain	VERB
gjear-961	104	19	glucosamine	glucosamine	NOUN
gjear-961	104	20	and	and	CCONJ
gjear-961	104	21	chondroitin	chondroitin	NOUN
gjear-961	104	22	simultaneously	simultaneously	ADV
gjear-961	104	23	.	.	PUNCT
gjear-961	105	1	the	the	DET
gjear-961	105	2	quantitative	quantitative	ADJ
gjear-961	105	3	results	result	NOUN
gjear-961	105	4	are	be	AUX
gjear-961	105	5	presented	present	VERB
gjear-961	105	6	in	in	ADP
gjear-961	105	7	table	table	NOUN
gjear-961	105	8	5	5	NUM
gjear-961	105	9	,	,	PUNCT
gjear-961	105	10	which	which	PRON
gjear-961	105	11	shows	show	VERB
gjear-961	105	12	that	that	SCONJ
gjear-961	105	13	two	two	NUM
gjear-961	105	14	samples	sample	NOUN
gjear-961	105	15	do	do	AUX
gjear-961	105	16	not	not	PART
gjear-961	105	17	meet	meet	VERB
gjear-961	105	18	the	the	DET
gjear-961	105	19	content	content	NOUN
gjear-961	105	20	requirement	requirement	NOUN
gjear-961	105	21	.	.	PUNCT
gjear-961	106	1	this	this	DET
gjear-961	106	2	result	result	NOUN
gjear-961	106	3	brings	bring	VERB
gjear-961	106	4	back	back	ADP
gjear-961	106	5	a	a	DET
gjear-961	106	6	reminder	reminder	NOUN
gjear-961	106	7	of	of	ADP
gjear-961	106	8	the	the	DET
gjear-961	106	9	necessity	necessity	NOUN
gjear-961	106	10	to	to	PART
gjear-961	106	11	have	have	AUX
gjear-961	106	12	the	the	DET
gjear-961	106	13	quantification	quantification	NOUN
gjear-961	106	14	process	process	NOUN
gjear-961	106	15	for	for	ADP
gjear-961	106	16	the	the	DET
gjear-961	106	17	quality	quality	NOUN
gjear-961	106	18	control	control	NOUN
gjear-961	106	19	of	of	ADP
gjear-961	106	20	the	the	DET
gjear-961	106	21	functional	functional	ADJ
gjear-961	106	22	foods	food	NOUN
gjear-961	106	23	sold	sell	VERB
gjear-961	106	24	in	in	ADP
gjear-961	106	25	the	the	DET
gjear-961	106	26	market	market	NOUN
gjear-961	106	27	.	.	PUNCT
gjear-961	107	1	table	table	NOUN
gjear-961	107	2	5	5	NUM
gjear-961	107	3	.	.	PUNCT
gjear-961	107	4	application	application	NOUN
gjear-961	107	5	study	study	NOUN
gjear-961	107	6	producer	producer	NOUN
gjear-961	107	7	content	content	NOUN
gjear-961	107	8	of	of	ADP
gjear-961	107	9	analytes	analyte	NOUN
gjear-961	107	10	(	(	PUNCT
gjear-961	107	11	%	%	NOUN
gjear-961	107	12	)	)	PUNCT
gjear-961	107	13	*	*	PUNCT
gjear-961	107	14	glucosamine	glucosamine	NOUN
gjear-961	107	15	chondroitin	chondroitin	NOUN
gjear-961	107	16	company	company	NOUN
gjear-961	107	17	a	a	DET
gjear-961	107	18	99.7	99.7	NUM
gjear-961	107	19	±	±	NUM
gjear-961	107	20	0.88	0.88	NUM
gjear-961	107	21	99.5	99.5	NUM
gjear-961	107	22	±	±	NUM
gjear-961	107	23	1.18	1.18	NUM
gjear-961	107	24	company	company	NOUN
gjear-961	107	25	b	b	PROPN
gjear-961	107	26	31.67	31.67	NUM
gjear-961	107	27	±	±	NUM
gjear-961	107	28	0.28	0.28	NUM
gjear-961	107	29	79.9	79.9	NUM
gjear-961	107	30	±	±	NUM
gjear-961	107	31	0.87	0.87	NUM
gjear-961	107	32	*	*	PUNCT
gjear-961	107	33	:	:	PUNCT
gjear-961	107	34	the	the	DET
gjear-961	107	35	mean	mean	ADJ
gjear-961	107	36	values	value	VERB
gjear-961	107	37	±	±	NOUN
gjear-961	107	38	sd	sd	ADP
gjear-961	107	39	(	(	PUNCT
gjear-961	107	40	n	n	NOUN
gjear-961	107	41	=	=	SYM
gjear-961	107	42	3	3	X
gjear-961	107	43	)	)	PUNCT
gjear-961	107	44	global	global	ADJ
gjear-961	107	45	research	research	PROPN
gjear-961	107	46	journal	journal	PROPN
gjear-961	107	47	of	of	ADP
gjear-961	107	48	management	management	NOUN
gjear-961	107	49	and	and	CCONJ
gjear-961	107	50	social	social	ADJ
gjear-961	107	51	sciences	science	NOUN
gjear-961	107	52	(	(	PUNCT
gjear-961	107	53	grjmss	grjmss	PROPN
gjear-961	107	54	)	)	PUNCT
gjear-961	107	55	vol	vol	NOUN
gjear-961	107	56	.	.	PROPN
gjear-961	107	57	13	13	NUM
gjear-961	107	58	(	(	PUNCT
gjear-961	107	59	12	12	NUM
gjear-961	107	60	)	)	PUNCT
gjear-961	107	61	pg	pg	NOUN
gjear-961	107	62	.	.	PROPN
gjear-961	108	1	25	25	NUM
gjear-961	108	2	4	4	NUM
gjear-961	108	3	.	.	PUNCT
gjear-961	108	4	conclusion	conclusion	VERB
gjear-961	108	5	a	a	DET
gjear-961	108	6	procedure	procedure	NOUN
gjear-961	108	7	for	for	ADP
gjear-961	108	8	glucosamine	glucosamine	NOUN
gjear-961	108	9	quantification	quantification	NOUN
gjear-961	108	10	by	by	ADP
gjear-961	108	11	pre	pre	ADJ
gjear-961	108	12	-	-	ADJ
gjear-961	108	13	column	column	ADJ
gjear-961	108	14	derivatization	derivatization	NOUN
gjear-961	108	15	with	with	ADP
gjear-961	108	16	fmoc	fmoc	NOUN
gjear-961	108	17	-	-	PUNCT
gjear-961	108	18	cl	cl	NOUN
gjear-961	108	19	reagent	reagent	NOUN
gjear-961	108	20	on	on	ADP
gjear-961	108	21	uplc	uplc	ADJ
gjear-961	108	22	acquity	acquity	NOUN
gjear-961	108	23	h	h	NOUN
gjear-961	108	24	-	-	PUNCT
gjear-961	108	25	class	class	NOUN
gjear-961	108	26	waters	water	NOUN
gjear-961	108	27	system	system	NOUN
gjear-961	108	28	tuv	tuv	PROPN
gjear-961	108	29	probe	probe	NOUN
gjear-961	108	30	,	,	PUNCT
gjear-961	108	31	with	with	ADP
gjear-961	108	32	c18	c18	NOUN
gjear-961	108	33	(	(	PUNCT
gjear-961	108	34	2.1	2.1	NUM
gjear-961	108	35	×	×	NOUN
gjear-961	108	36	100	100	NUM
gjear-961	108	37	mm	mm	NOUN
gjear-961	108	38	,	,	PUNCT
gjear-961	108	39	1.7	1.7	NUM
gjear-961	108	40	μm	μm	NUM
gjear-961	108	41	)	)	PUNCT
gjear-961	108	42	,	,	PUNCT
gjear-961	108	43	mobile	mobile	ADJ
gjear-961	108	44	phase	phase	NOUN
gjear-961	108	45	consisting	consist	VERB
gjear-961	108	46	of	of	ADP
gjear-961	108	47	acn	acn	PROPN
gjear-961	108	48	–	–	PUNCT
gjear-961	108	49	water	water	NOUN
gjear-961	108	50	with	with	ADP
gjear-961	108	51	gradient	gradient	ADJ
gjear-961	108	52	elution	elution	NOUN
gjear-961	108	53	program	program	NOUN
gjear-961	108	54	and	and	CCONJ
gjear-961	108	55	a	a	DET
gjear-961	108	56	process	process	NOUN
gjear-961	108	57	to	to	PART
gjear-961	108	58	quantify	quantify	VERB
gjear-961	108	59	chondroitin	chondroitin	NOUN
gjear-961	108	60	by	by	ADP
gjear-961	108	61	uplc	uplc	PROPN
gjear-961	108	62	/	/	SYM
gjear-961	108	63	tuv	tuv	PROPN
gjear-961	108	64	system	system	NOUN
gjear-961	108	65	,	,	PUNCT
gjear-961	108	66	with	with	ADP
gjear-961	108	67	beh	beh	PROPN
gjear-961	108	68	hilic	hilic	PROPN
gjear-961	108	69	column	column	NOUN
gjear-961	108	70	(	(	PUNCT
gjear-961	108	71	2.1	2.1	NUM
gjear-961	108	72	×	×	NOUN
gjear-961	108	73	100	100	NUM
gjear-961	108	74	mm	mm	NOUN
gjear-961	108	75	,	,	PUNCT
gjear-961	108	76	1.7	1.7	NUM
gjear-961	108	77	μm	μm	NUM
gjear-961	108	78	)	)	PUNCT
gjear-961	108	79	,	,	PUNCT
gjear-961	108	80	mobile	mobile	ADJ
gjear-961	108	81	phase	phase	NOUN
gjear-961	108	82	consisting	consist	VERB
gjear-961	108	83	50:50	50:50	NUM
gjear-961	108	84	acn	acn	PROPN
gjear-961	108	85	–	–	PUNCT
gjear-961	108	86	5	5	NUM
gjear-961	108	87	mm	mm	NOUN
gjear-961	108	88	ammonium	ammonium	NOUN
gjear-961	108	89	acetate	acetate	NOUN
gjear-961	108	90	(	(	PUNCT
gjear-961	108	91	ph	ph	PROPN
gjear-961	108	92	8)	8)	NUM
gjear-961	108	93	were	be	AUX
gjear-961	108	94	researched	research	VERB
gjear-961	108	95	.	.	PUNCT
gjear-961	109	1	both	both	DET
gjear-961	109	2	procedures	procedure	NOUN
gjear-961	109	3	were	be	AUX
gjear-961	109	4	validated	validate	VERB
gjear-961	109	5	according	accord	VERB
gjear-961	109	6	to	to	ADP
gjear-961	109	7	ich	ich	NOUN
gjear-961	109	8	guidelines	guideline	NOUN
gjear-961	109	9	to	to	PART
gjear-961	109	10	fully	fully	ADV
gjear-961	109	11	meet	meet	VERB
gjear-961	109	12	the	the	DET
gjear-961	109	13	requirements	requirement	NOUN
gjear-961	109	14	of	of	ADP
gjear-961	109	15	a	a	DET
gjear-961	109	16	quantitative	quantitative	ADJ
gjear-961	109	17	analytical	analytical	ADJ
gjear-961	109	18	procedure	procedure	NOUN
gjear-961	109	19	,	,	PUNCT
gjear-961	109	20	including	include	VERB
gjear-961	109	21	selectivity	selectivity	NOUN
gjear-961	109	22	,	,	PUNCT
gjear-961	109	23	linearity	linearity	NOUN
gjear-961	109	24	,	,	PUNCT
gjear-961	109	25	accuracy	accuracy	NOUN
gjear-961	109	26	,	,	PUNCT
gjear-961	109	27	and	and	CCONJ
gjear-961	109	28	precision	precision	NOUN
gjear-961	109	29	.	.	PUNCT
gjear-961	110	1	experiment	experiment	NOUN
gjear-961	110	2	for	for	ADP
gjear-961	110	3	quantifying	quantify	VERB
gjear-961	110	4	glucosamine	glucosamine	NOUN
gjear-961	110	5	and	and	CCONJ
gjear-961	110	6	chondroitin	chondroitin	NOUN
gjear-961	110	7	in	in	ADP
gjear-961	110	8	dietary	dietary	ADJ
gjear-961	110	9	supplements	supplement	NOUN
gjear-961	110	10	was	be	AUX
gjear-961	110	11	proved	prove	VERB
gjear-961	110	12	to	to	PART
gjear-961	110	13	be	be	AUX
gjear-961	110	14	a	a	DET
gjear-961	110	15	potential	potential	ADJ
gjear-961	110	16	application	application	NOUN
gjear-961	110	17	and	and	CCONJ
gjear-961	110	18	pharmaceuticals	pharmaceutical	NOUN
gjear-961	110	19	.	.	PUNCT
gjear-961	111	1	acknowledgment	acknowledgment	NOUN
gjear-961	111	2	an	an	DET
gjear-961	111	3	acknowledgements	acknowledgement	NOUN
gjear-961	111	4	section	section	NOUN
gjear-961	111	5	is	be	AUX
gjear-961	111	6	optional	optional	ADJ
gjear-961	111	7	and	and	CCONJ
gjear-961	111	8	may	may	AUX
gjear-961	111	9	recognize	recognize	VERB
gjear-961	111	10	those	those	DET
gjear-961	111	11	individuals	individual	NOUN
gjear-961	111	12	who	who	PRON
gjear-961	111	13	provided	provide	VERB
gjear-961	111	14	help	help	NOUN
gjear-961	111	15	during	during	ADP
gjear-961	111	16	the	the	DET
gjear-961	111	17	research	research	NOUN
gjear-961	111	18	and	and	CCONJ
gjear-961	111	19	preparation	preparation	NOUN
gjear-961	111	20	of	of	ADP
gjear-961	111	21	the	the	DET
gjear-961	111	22	manuscript	manuscript	NOUN
gjear-961	111	23	.	.	PUNCT
gjear-961	112	1	conflict	conflict	NOUN
gjear-961	112	2	of	of	ADP
gjear-961	112	3	interest	interest	NOUN
gjear-961	112	4	.	.	PUNCT
gjear-961	113	1	the	the	DET
gjear-961	113	2	authors	author	NOUN
gjear-961	113	3	declare	declare	VERB
gjear-961	113	4	that	that	SCONJ
gjear-961	113	5	there	there	PRON
gjear-961	113	6	are	be	VERB
gjear-961	113	7	no	no	DET
gjear-961	113	8	conflicts	conflict	NOUN
gjear-961	113	9	of	of	ADP
gjear-961	113	10	interest	interest	NOUN
gjear-961	113	11	regarding	regard	VERB
gjear-961	113	12	the	the	DET
gjear-961	113	13	publication	publication	NOUN
gjear-961	113	14	of	of	ADP
gjear-961	113	15	this	this	DET
gjear-961	113	16	paper	paper	NOUN
gjear-961	113	17	.	.	PUNCT
gjear-961	114	1	orcid	orcid	NOUN
gjear-961	115	1	i	i	PRON
gjear-961	115	2	d	d	PROPN
gjear-961	115	3	ngoc	ngoc	PROPN
gjear-961	115	4	-	-	PUNCT
gjear-961	115	5	van	van	PROPN
gjear-961	115	6	thi	thi	PROPN
gjear-961	115	7	nguyen	nguyen	NOUN
gjear-961	115	8	:	:	PUNCT
gjear-961	116	1	https://orcid.org/0000-0002-7397-4071	https://orcid.org/0000-0002-7397-4071	PROPN
gjear-961	116	2	kim	kim	PROPN
gjear-961	116	3	-	-	PUNCT
gjear-961	116	4	ngan	ngan	PROPN
gjear-961	116	5	huynh	huynh	PROPN
gjear-961	116	6	nguyen	nguyen	PROPN
gjear-961	116	7	:	:	PUNCT
gjear-961	116	8	https://orcid.org/0000-0001-9914-9224	https://orcid.org/0000-0001-9914-9224	PROPN
gjear-961	116	9	references	reference	VERB
gjear-961	116	10	government	government	NOUN
gjear-961	116	11	chemist	chemist	NOUN
gjear-961	116	12	(	(	PUNCT
gjear-961	116	13	2012	2012	NUM
gjear-961	116	14	)	)	PUNCT
gjear-961	116	15	.	.	PUNCT
gjear-961	117	1	a	a	DET
gjear-961	117	2	review	review	NOUN
gjear-961	117	3	of	of	ADP
gjear-961	117	4	methods	method	NOUN
gjear-961	117	5	available	available	ADJ
gjear-961	117	6	for	for	ADP
gjear-961	117	7	the	the	DET
gjear-961	117	8	determination	determination	NOUN
gjear-961	117	9	of	of	ADP
gjear-961	117	10	chondroitin	chondroitin	NOUN
gjear-961	117	11	sulpahte	sulpahte	NOUN
gjear-961	117	12	in	in	ADP
gjear-961	117	13	supplement	supplement	NOUN
gjear-961	117	14	.	.	PUNCT
gjear-961	118	1	middlesex	middlesex	NOUN
gjear-961	118	2	,	,	PUNCT
gjear-961	118	3	tw11	tw11	PROPN
gjear-961	118	4	0ly	0ly	NOUN
gjear-961	118	5	,	,	PUNCT
gjear-961	118	6	pp1	pp1	NOUN
gjear-961	118	7	-	-	PUNCT
gjear-961	118	8	5	5	NUM
gjear-961	118	9	.	.	PUNCT
gjear-961	119	1	anderson	anderson	PROPN
gjear-961	119	2	,	,	PUNCT
gjear-961	119	3	j.w	j.w	PROPN
gjear-961	119	4	.	.	PROPN
gjear-961	119	5	,	,	PUNCT
gjear-961	119	6	nicolosi	nicolosi	PROPN
gjear-961	119	7	,	,	PUNCT
gjear-961	119	8	r.j	r.j	PROPN
gjear-961	119	9	.	.	PROPN
gjear-961	119	10	&	&	CCONJ
gjear-961	119	11	borzelleca	borzelleca	PROPN
gjear-961	119	12	,	,	PUNCT
gjear-961	119	13	j.f	j.f	PROPN
gjear-961	119	14	.	.	PROPN
gjear-961	119	15	(	(	PUNCT
gjear-961	119	16	2005	2005	NUM
gjear-961	119	17	)	)	PUNCT
gjear-961	119	18	.	.	PUNCT
gjear-961	120	1	glucosamine	glucosamine	NOUN
gjear-961	120	2	effects	effect	NOUN
gjear-961	120	3	in	in	ADP
gjear-961	120	4	humans	human	NOUN
gjear-961	120	5	:	:	PUNCT
gjear-961	120	6	a	a	DET
gjear-961	120	7	review	review	NOUN
gjear-961	120	8	of	of	ADP
gjear-961	120	9	effects	effect	NOUN
gjear-961	120	10	on	on	ADP
gjear-961	120	11	glucose	glucose	NOUN
gjear-961	120	12	metabolism	metabolism	NOUN
gjear-961	120	13	,	,	PUNCT
gjear-961	120	14	side	side	NOUN
gjear-961	120	15	effects	effect	NOUN
gjear-961	120	16	,	,	PUNCT
gjear-961	120	17	safety	safety	NOUN
gjear-961	120	18	considerations	consideration	NOUN
gjear-961	120	19	and	and	CCONJ
gjear-961	120	20	efficacy	efficacy	NOUN
gjear-961	120	21	.	.	PUNCT
gjear-961	121	1	food	food	NOUN
gjear-961	121	2	and	and	CCONJ
gjear-961	121	3	chemical	chemical	NOUN
gjear-961	121	4	toxicology	toxicology	NOUN
gjear-961	121	5	,	,	PUNCT
gjear-961	121	6	43(2	43(2	PROPN
gjear-961	121	7	)	)	PUNCT
gjear-961	121	8	,	,	PUNCT
gjear-961	121	9	187	187	NUM
gjear-961	121	10	-	-	SYM
gjear-961	121	11	201	201	NUM
gjear-961	121	12	.	.	PUNCT
gjear-961	122	1	british	british	ADJ
gjear-961	122	2	pharmacopoeia	pharmacopoeia	PROPN
gjear-961	122	3	(	(	PUNCT
gjear-961	122	4	bp	bp	PROPN
gjear-961	122	5	,	,	PUNCT
gjear-961	122	6	2016	2016	NUM
gjear-961	122	7	)	)	PUNCT
gjear-961	122	8	.	.	PUNCT
gjear-961	123	1	1091	1091	NUM
gjear-961	123	2	-	-	SYM
gjear-961	123	3	1093	1093	NUM
gjear-961	123	4	.	.	PUNCT
gjear-961	124	1	harmita	harmita	PROPN
gjear-961	124	2	,	,	PUNCT
gjear-961	124	3	h.	h.	PROPN
gjear-961	124	4	,	,	PUNCT
gjear-961	124	5	jatmika	jatmika	NOUN
gjear-961	124	6	,	,	PUNCT
gjear-961	124	7	c.	c.	PROPN
gjear-961	124	8	&	&	CCONJ
gjear-961	124	9	nugraha	nugraha	PROPN
gjear-961	124	10	,	,	PUNCT
gjear-961	124	11	m.i	m.i	PROPN
gjear-961	124	12	.	.	PROPN
gjear-961	124	13	(	(	PUNCT
gjear-961	124	14	2017	2017	NUM
gjear-961	124	15	)	)	PUNCT
gjear-961	124	16	.	.	PUNCT
gjear-961	125	1	determination	determination	NOUN
gjear-961	125	2	of	of	ADP
gjear-961	125	3	levels	level	NOUN
gjear-961	125	4	of	of	ADP
gjear-961	125	5	glucosamine	glucosamine	NOUN
gjear-961	125	6	hydrochloride	hydrochloride	NOUN
gjear-961	125	7	and	and	CCONJ
gjear-961	125	8	chondroitin	chondroitin	NOUN
gjear-961	125	9	sulfate	sulfate	NOUN
gjear-961	125	10	in	in	ADP
gjear-961	125	11	mixtures	mixture	NOUN
gjear-961	125	12	in	in	ADP
gjear-961	125	13	tablet	tablet	NOUN
gjear-961	125	14	and	and	CCONJ
gjear-961	125	15	cream	cream	NOUN
gjear-961	125	16	forms	form	NOUN
gjear-961	125	17	using	use	VERB
gjear-961	125	18	high	high	ADJ
gjear-961	125	19	-	-	PUNCT
gjear-961	125	20	performance	performance	NOUN
gjear-961	125	21	liquid	liquid	ADJ
gjear-961	125	22	chromatography	chromatography	NOUN
gjear-961	125	23	with	with	ADP
gjear-961	125	24	fluorescence	fluorescence	NOUN
gjear-961	125	25	.	.	PUNCT
gjear-961	126	1	international	international	ADJ
gjear-961	126	2	journal	journal	NOUN
gjear-961	126	3	of	of	ADP
gjear-961	126	4	applied	apply	VERB
gjear-961	126	5	pharmaceutics	pharmaceutic	NOUN
gjear-961	126	6	,	,	PUNCT
gjear-961	126	7	9	9	NUM
gjear-961	126	8	,	,	PUNCT
gjear-961	126	9	144	144	NUM
gjear-961	126	10	-	-	SYM
gjear-961	126	11	149	149	NUM
gjear-961	126	12	.	.	PUNCT
gjear-961	127	1	huang	huang	PROPN
gjear-961	127	2	,	,	PUNCT
gjear-961	127	3	t.m	t.m	PROPN
gjear-961	127	4	.	.	PROPN
gjear-961	127	5	,	,	PUNCT
gjear-961	127	6	deng	deng	PROPN
gjear-961	127	7	,	,	PUNCT
gjear-961	127	8	c.h	c.h	PROPN
gjear-961	127	9	.	.	PROPN
gjear-961	127	10	,	,	PUNCT
gjear-961	127	11	chen	chen	PROPN
gjear-961	127	12	,	,	PUNCT
gjear-961	127	13	n.z	n.z	PROPN
gjear-961	127	14	.	.	PROPN
gjear-961	127	15	,	,	PUNCT
gjear-961	127	16	liu	liu	PROPN
gjear-961	127	17	,	,	PUNCT
gjear-961	127	18	z.	z.	PROPN
gjear-961	127	19	&	&	CCONJ
gjear-961	127	20	duan	duan	PROPN
gjear-961	127	21	,	,	PUNCT
gjear-961	127	22	g.l	g.l	PROPN
gjear-961	127	23	.	.	PROPN
gjear-961	127	24	(	(	PUNCT
gjear-961	127	25	2006	2006	NUM
gjear-961	127	26	)	)	PUNCT
gjear-961	127	27	.	.	PUNCT
gjear-961	128	1	high	high	ADJ
gjear-961	128	2	performance	performance	NOUN
gjear-961	128	3	liquid	liquid	NOUN
gjear-961	128	4	chromatography	chromatography	NOUN
gjear-961	128	5	for	for	ADP
gjear-961	128	6	the	the	DET
gjear-961	128	7	determination	determination	NOUN
gjear-961	128	8	of	of	ADP
gjear-961	128	9	glucosamine	glucosamine	NOUN
gjear-961	128	10	sulfate	sulfate	NOUN
gjear-961	128	11	in	in	ADP
gjear-961	128	12	human	human	ADJ
gjear-961	128	13	plasma	plasma	NOUN
gjear-961	128	14	after	after	ADP
gjear-961	128	15	derivatization	derivatization	NOUN
gjear-961	128	16	with	with	ADP
gjear-961	128	17	9‐	9‐	NUM
gjear-961	128	18	fluorenylmethyl	fluorenylmethyl	NOUN
gjear-961	128	19	chloroformate	chloroformate	NOUN
gjear-961	128	20	.	.	PUNCT
gjear-961	129	1	journal	journal	PROPN
gjear-961	129	2	of	of	ADP
gjear-961	129	3	separation	separation	NOUN
gjear-961	129	4	science	science	NOUN
gjear-961	129	5	,	,	PUNCT
gjear-961	129	6	29(15	29(15	NUM
gjear-961	129	7	)	)	PUNCT
gjear-961	129	8	,	,	PUNCT
gjear-961	129	9	2296	2296	NUM
gjear-961	129	10	-	-	SYM
gjear-961	129	11	2302	2302	NUM
gjear-961	129	12	.	.	PUNCT
gjear-961	130	1	huang	huang	PROPN
gjear-961	130	2	,	,	PUNCT
gjear-961	130	3	r.	r.	PROPN
gjear-961	130	4	,	,	PUNCT
gjear-961	130	5	pomin	pomin	PROPN
gjear-961	130	6	,	,	PUNCT
gjear-961	130	7	v.h	v.h	PROPN
gjear-961	130	8	.	.	PROPN
gjear-961	130	9	&	&	CCONJ
gjear-961	130	10	sharp	sharp	PROPN
gjear-961	130	11	,	,	PUNCT
gjear-961	130	12	j.s	j.s	PROPN
gjear-961	130	13	.	.	PUNCT
gjear-961	130	14	(	(	PUNCT
gjear-961	130	15	2011	2011	NUM
gjear-961	130	16	)	)	PUNCT
gjear-961	130	17	.	.	PUNCT
gjear-961	131	1	lc	lc	PROPN
gjear-961	131	2	-	-	PUNCT
gjear-961	131	3	ms	ms	NOUN
gjear-961	131	4	n	n	PRON
gjear-961	131	5	analysis	analysis	NOUN
gjear-961	131	6	of	of	ADP
gjear-961	131	7	isomeric	isomeric	ADJ
gjear-961	131	8	chondroitin	chondroitin	NOUN
gjear-961	131	9	sulfate	sulfate	NOUN
gjear-961	131	10	oligosaccharides	oligosaccharide	NOUN
gjear-961	131	11	using	use	VERB
gjear-961	131	12	a	a	DET
gjear-961	131	13	chemical	chemical	ADJ
gjear-961	131	14	derivatization	derivatization	NOUN
gjear-961	131	15	strategy	strategy	NOUN
gjear-961	131	16	.	.	PUNCT
gjear-961	132	1	journal	journal	NOUN
gjear-961	132	2	of	of	ADP
gjear-961	132	3	the	the	DET
gjear-961	132	4	american	american	ADJ
gjear-961	132	5	society	society	NOUN
gjear-961	132	6	for	for	ADP
gjear-961	132	7	mass	mass	ADJ
gjear-961	132	8	spectrometry	spectrometry	NOUN
gjear-961	132	9	,	,	PUNCT
gjear-961	132	10	22(9	22(9	NUM
gjear-961	132	11	)	)	PUNCT
gjear-961	132	12	,	,	PUNCT
gjear-961	132	13	1577	1577	NUM
gjear-961	132	14	-	-	SYM
gjear-961	132	15	87	87	NUM
gjear-961	132	16	.	.	PUNCT
gjear-961	133	1	guideline	guideline	NOUN
gjear-961	133	2	,	,	PUNCT
gjear-961	133	3	i.c.h	i.c.h	NOUN
gjear-961	133	4	.	.	PUNCT
gjear-961	134	1	(	(	PUNCT
gjear-961	134	2	2005	2005	NUM
gjear-961	134	3	)	)	PUNCT
gjear-961	134	4	.	.	PUNCT
gjear-961	135	1	validation	validation	NOUN
gjear-961	135	2	of	of	ADP
gjear-961	135	3	analytical	analytical	ADJ
gjear-961	135	4	procedures	procedure	NOUN
gjear-961	135	5	:	:	PUNCT
gjear-961	135	6	text	text	NOUN
gjear-961	135	7	and	and	CCONJ
gjear-961	135	8	methodology	methodology	NOUN
gjear-961	135	9	.	.	PUNCT
gjear-961	136	1	q2	q2	NOUN
gjear-961	136	2	(	(	PUNCT
gjear-961	136	3	r1	r1	PROPN
gjear-961	136	4	)	)	PUNCT
gjear-961	136	5	,	,	PUNCT
gjear-961	136	6	1(20	1(20	NUM
gjear-961	136	7	)	)	PUNCT
gjear-961	136	8	,	,	PUNCT
gjear-961	136	9	05	05	NUM
gjear-961	136	10	.	.	PUNCT
gjear-961	137	1	jámbor	jámbor	PROPN
gjear-961	137	2	,	,	PUNCT
gjear-961	137	3	a.	a.	PROPN
gjear-961	137	4	&	&	CCONJ
gjear-961	137	5	molnár	molnár	PROPN
gjear-961	137	6	-	-	PROPN
gjear-961	137	7	perl	perl	NOUN
gjear-961	137	8	,	,	PUNCT
gjear-961	137	9	i.	i.	NOUN
gjear-961	137	10	(	(	PUNCT
gjear-961	137	11	2009	2009	NUM
gjear-961	137	12	)	)	PUNCT
gjear-961	137	13	.	.	PUNCT
gjear-961	138	1	quantitation	quantitation	NOUN
gjear-961	138	2	of	of	ADP
gjear-961	138	3	amino	amino	ADJ
gjear-961	138	4	acids	acid	NOUN
gjear-961	138	5	in	in	ADP
gjear-961	138	6	plasma	plasma	NOUN
gjear-961	138	7	by	by	ADP
gjear-961	138	8	high	high	ADJ
gjear-961	138	9	performance	performance	NOUN
gjear-961	138	10	liquid	liquid	NOUN
gjear-961	138	11	chromatography	chromatography	NOUN
gjear-961	138	12	:	:	PUNCT
gjear-961	138	13	simultaneous	simultaneous	ADJ
gjear-961	138	14	deproteinization	deproteinization	NOUN
gjear-961	138	15	and	and	CCONJ
gjear-961	138	16	derivatization	derivatization	NOUN
gjear-961	138	17	with	with	ADP
gjear-961	138	18	9	9	NUM
gjear-961	138	19	-	-	PUNCT
gjear-961	138	20	fluorenylmethyloxycarbonyl	fluorenylmethyloxycarbonyl	NOUN
gjear-961	138	21	chloride	chloride	NOUN
gjear-961	138	22	.	.	PUNCT
gjear-961	139	1	journal	journal	PROPN
gjear-961	139	2	of	of	ADP
gjear-961	139	3	chromatography	chromatography	PROPN
gjear-961	139	4	a	a	PRON
gjear-961	139	5	,	,	PUNCT
gjear-961	139	6	1216(34	1216(34	NUM
gjear-961	139	7	)	)	PUNCT
gjear-961	139	8	,	,	PUNCT
gjear-961	139	9	6218	6218	NUM
gjear-961	139	10	-	-	SYM
gjear-961	139	11	6223	6223	NUM
gjear-961	139	12	.	.	PUNCT
gjear-961	140	1	https://orcid.org/0000-0002-7397-4071	https://orcid.org/0000-0002-7397-4071	PROPN
gjear-961	140	2	https://orcid.org/0000-0002-7397-4071	https://orcid.org/0000-0002-7397-4071	PROPN
gjear-961	140	3	https://orcid.org/0000-0002-7397-4071	https://orcid.org/0000-0002-7397-4071	PROPN
gjear-961	140	4	https://orcid.org/0000-0002-7397-4071	https://orcid.org/0000-0002-7397-4071	PROPN
gjear-961	140	5	https://orcid.org/0000-0002-7397-4071	https://orcid.org/0000-0002-7397-4071	ADJ
gjear-961	140	6	https://orcid.org/0000-0002-7397-4071	https://orcid.org/0000-0002-7397-4071	ADJ
gjear-961	140	7	https://orcid.org/0000-0002-7397-4071	https://orcid.org/0000-0002-7397-4071	PROPN
gjear-961	140	8	https://orcid.org/0000-0002-7397-4071	https://orcid.org/0000-0002-7397-4071	ADJ
gjear-961	140	9	https://orcid.org/0000-0002-7397-4071	https://orcid.org/0000-0002-7397-4071	ADV
gjear-961	140	10	https://orcid.org/0000-0001-9914-9224	https://orcid.org/0000-0001-9914-9224	X
gjear-961	140	11	https://orcid.org/0000-0001-9914-9224	https://orcid.org/0000-0001-9914-9224	X
gjear-961	140	12	https://orcid.org/0000-0001-9914-9224	https://orcid.org/0000-0001-9914-9224	X
gjear-961	140	13	https://orcid.org/0000-0001-9914-9224	https://orcid.org/0000-0001-9914-9224	X
gjear-961	140	14	https://orcid.org/0000-0001-9914-9224	https://orcid.org/0000-0001-9914-9224	X
gjear-961	140	15	https://orcid.org/0000-0001-9914-9224	https://orcid.org/0000-0001-9914-9224	X
gjear-961	140	16	https://orcid.org/0000-0001-9914-9224	https://orcid.org/0000-0001-9914-9224	X
gjear-961	140	17	https://orcid.org/0000-0001-9914-9224	https://orcid.org/0000-0001-9914-9224	PROPN
gjear-961	140	18	https://orcid.org/0000-0001-9914-9224	https://orcid.org/0000-0001-9914-9224	PROPN
gjear-961	140	19	global	global	PROPN
gjear-961	140	20	research	research	PROPN
gjear-961	140	21	journal	journal	PROPN
gjear-961	140	22	of	of	ADP
gjear-961	140	23	management	management	NOUN
gjear-961	140	24	and	and	CCONJ
gjear-961	140	25	social	social	ADJ
gjear-961	140	26	sciences	science	NOUN
gjear-961	140	27	(	(	PUNCT
gjear-961	140	28	grjmss	grjmss	PROPN
gjear-961	140	29	)	)	PUNCT
gjear-961	140	30	vol	vol	NOUN
gjear-961	140	31	.	.	PROPN
gjear-961	140	32	13	13	NUM
gjear-961	140	33	(	(	PUNCT
gjear-961	140	34	12	12	NUM
gjear-961	140	35	)	)	PUNCT
gjear-961	140	36	pg	pg	NOUN
gjear-961	140	37	.	.	PROPN
gjear-961	141	1	26	26	NUM
gjear-961	141	2	kosman	kosman	PROPN
gjear-961	141	3	,	,	PUNCT
gjear-961	141	4	v.m	v.m	PROPN
gjear-961	141	5	.	.	PROPN
gjear-961	141	6	,	,	PUNCT
gjear-961	141	7	karlina	karlina	PROPN
gjear-961	141	8	,	,	PUNCT
gjear-961	141	9	m.n	m.n	PROPN
gjear-961	141	10	.	.	PROPN
gjear-961	141	11	,	,	PUNCT
gjear-961	141	12	pozharitskaya	pozharitskaya	PROPN
gjear-961	141	13	,	,	PUNCT
gjear-961	141	14	o.n	o.n	PROPN
gjear-961	141	15	.	.	PROPN
gjear-961	141	16	,	,	PUNCT
gjear-961	141	17	shikov	shikov	PROPN
gjear-961	141	18	,	,	PUNCT
gjear-961	141	19	a.n	a.n	PROPN
gjear-961	141	20	.	.	PROPN
gjear-961	141	21	&	&	CCONJ
gjear-961	141	22	makarov	makarov	PROPN
gjear-961	141	23	,	,	PUNCT
gjear-961	141	24	v.g	v.g	PROPN
gjear-961	141	25	.	.	PROPN
gjear-961	141	26	(	(	PUNCT
gjear-961	141	27	2017	2017	NUM
gjear-961	141	28	)	)	PUNCT
gjear-961	141	29	.	.	PUNCT
gjear-961	142	1	hplc	hplc	NOUN
gjear-961	142	2	determination	determination	NOUN
gjear-961	142	3	of	of	ADP
gjear-961	142	4	glucosamine	glucosamine	NOUN
gjear-961	142	5	hydrochloride	hydrochloride	NOUN
gjear-961	142	6	and	and	CCONJ
gjear-961	142	7	chondroitin	chondroitin	NOUN
gjear-961	142	8	sulfate	sulfate	NOUN
gjear-961	142	9	,	,	PUNCT
gjear-961	142	10	weakly	weakly	ADV
gjear-961	142	11	absorbing	absorbing	NOUN
gjear-961	142	12	in	in	ADP
gjear-961	142	13	the	the	DET
gjear-961	142	14	near	near	ADJ
gjear-961	142	15	uv	uv	NOUN
gjear-961	142	16	region	region	NOUN
gjear-961	142	17	,	,	PUNCT
gjear-961	142	18	in	in	ADP
gjear-961	142	19	various	various	ADJ
gjear-961	142	20	buffer	buffer	NOUN
gjear-961	142	21	media	medium	NOUN
gjear-961	142	22	.	.	PUNCT
gjear-961	143	1	journal	journal	NOUN
gjear-961	143	2	of	of	ADP
gjear-961	143	3	analytical	analytical	ADJ
gjear-961	143	4	chemistry	chemistry	NOUN
gjear-961	143	5	,	,	PUNCT
gjear-961	143	6	72(8	72(8	NUM
gjear-961	143	7	)	)	PUNCT
gjear-961	143	8	,	,	PUNCT
gjear-961	143	9	879	879	NUM
gjear-961	143	10	-	-	SYM
gjear-961	143	11	885	885	NUM
gjear-961	143	12	.	.	PUNCT
gjear-961	144	1	liang	liang	PROPN
gjear-961	144	2	,	,	PUNCT
gjear-961	144	3	x.	x.	PROPN
gjear-961	144	4	,	,	PUNCT
gjear-961	144	5	zhang	zhang	PROPN
gjear-961	144	6	,	,	PUNCT
gjear-961	144	7	l.	l.	PROPN
gjear-961	144	8	,	,	PUNCT
gjear-961	144	9	zhang	zhang	PROPN
gjear-961	144	10	,	,	PUNCT
gjear-961	144	11	x.	x.	PROPN
gjear-961	144	12	,	,	PUNCT
gjear-961	144	13	dai	dai	PROPN
gjear-961	144	14	,	,	PUNCT
gjear-961	144	15	w.	w.	PROPN
gjear-961	144	16	,	,	PUNCT
gjear-961	144	17	li	li	PROPN
gjear-961	144	18	,	,	PUNCT
gjear-961	144	19	h.	h.	PROPN
gjear-961	144	20	,	,	PUNCT
gjear-961	144	21	hu	hu	PROPN
gjear-961	144	22	,	,	PUNCT
gjear-961	144	23	l.	l.	PROPN
gjear-961	144	24	&	&	CCONJ
gjear-961	144	25	zhang	zhang	PROPN
gjear-961	144	26	,	,	PUNCT
gjear-961	144	27	w.	w.	PROPN
gjear-961	144	28	(	(	PUNCT
gjear-961	144	29	2010	2010	NUM
gjear-961	144	30	)	)	PUNCT
gjear-961	144	31	.	.	PUNCT
gjear-961	145	1	qualitative	qualitative	ADJ
gjear-961	145	2	and	and	CCONJ
gjear-961	145	3	quantitative	quantitative	ADJ
gjear-961	145	4	analysis	analysis	NOUN
gjear-961	145	5	of	of	ADP
gjear-961	145	6	traditional	traditional	ADJ
gjear-961	145	7	chinese	chinese	ADJ
gjear-961	145	8	medicine	medicine	PROPN
gjear-961	145	9	niu	niu	PROPN
gjear-961	145	10	huang	huang	PROPN
gjear-961	145	11	jie	jie	PROPN
gjear-961	145	12	du	du	PROPN
gjear-961	145	13	pill	pill	NOUN
gjear-961	145	14	using	use	VERB
gjear-961	145	15	ultra	ultra	ADJ
gjear-961	145	16	performance	performance	NOUN
gjear-961	145	17	liquid	liquid	ADJ
gjear-961	145	18	chromatography	chromatography	NOUN
gjear-961	145	19	coupled	couple	VERB
gjear-961	145	20	with	with	ADP
gjear-961	145	21	tunable	tunable	ADJ
gjear-961	145	22	uv	uv	NOUN
gjear-961	145	23	detector	detector	NOUN
gjear-961	145	24	and	and	CCONJ
gjear-961	145	25	rapid	rapid	ADJ
gjear-961	145	26	resolution	resolution	NOUN
gjear-961	145	27	liquid	liquid	ADJ
gjear-961	145	28	chromatography	chromatography	NOUN
gjear-961	145	29	coupled	couple	VERB
gjear-961	145	30	with	with	ADP
gjear-961	145	31	time	time	NOUN
gjear-961	145	32	-	-	PUNCT
gjear-961	145	33	of	of	ADP
gjear-961	145	34	-	-	PUNCT
gjear-961	145	35	flight	flight	NOUN
gjear-961	145	36	tandem	tandem	NOUN
gjear-961	145	37	mass	mass	PROPN
gjear-961	145	38	spectrometry	spectrometry	NOUN
gjear-961	145	39	.	.	PUNCT
gjear-961	146	1	journal	journal	PROPN
gjear-961	146	2	of	of	ADP
gjear-961	146	3	pharmaceutical	pharmaceutical	NOUN
gjear-961	146	4	and	and	CCONJ
gjear-961	146	5	biomedical	biomedical	ADJ
gjear-961	146	6	analysis	analysis	NOUN
gjear-961	146	7	,	,	PUNCT
gjear-961	146	8	51(3	51(3	NUM
gjear-961	146	9	)	)	PUNCT
gjear-961	146	10	,	,	PUNCT
gjear-961	146	11	565	565	NUM
gjear-961	146	12	-	-	SYM
gjear-961	146	13	571	571	NUM
gjear-961	146	14	.	.	PUNCT
gjear-961	147	1	martel	martel	NOUN
gjear-961	147	2	-	-	PUNCT
gjear-961	147	3	pelletier	pelletier	PROPN
gjear-961	147	4	,	,	PUNCT
gjear-961	147	5	j.	j.	PROPN
gjear-961	147	6	,	,	PUNCT
gjear-961	147	7	lajeunesse	lajeunesse	INTJ
gjear-961	147	8	,	,	PUNCT
gjear-961	147	9	d.	d.	PROPN
gjear-961	147	10	&	&	CCONJ
gjear-961	147	11	pelletier	pelletier	PROPN
gjear-961	147	12	,	,	PUNCT
gjear-961	147	13	j.p	j.p	PROPN
gjear-961	147	14	.	.	PROPN
gjear-961	147	15	(	(	PUNCT
gjear-961	147	16	2005	2005	NUM
gjear-961	147	17	)	)	PUNCT
gjear-961	147	18	.	.	PUNCT
gjear-961	148	1	etiopathogenesis	etiopathogenesis	NOUN
gjear-961	148	2	of	of	ADP
gjear-961	148	3	osteoarthritis	osteoarthritis	NOUN
gjear-961	148	4	,	,	PUNCT
gjear-961	148	5	in	in	ADP
gjear-961	148	6	:	:	PUNCT
gjear-961	148	7	koopman	koopman	PROPN
gjear-961	148	8	,	,	PUNCT
gjear-961	148	9	w.j	w.j	PROPN
gjear-961	148	10	.	.	PROPN
gjear-961	148	11	&	&	CCONJ
gjear-961	148	12	moreland	moreland	PROPN
gjear-961	148	13	,	,	PUNCT
gjear-961	148	14	l.w	l.w	PROPN
gjear-961	148	15	.	.	PUNCT
gjear-961	148	16	(	(	PUNCT
gjear-961	148	17	eds	ed	NOUN
gjear-961	148	18	.	.	PUNCT
gjear-961	148	19	)	)	PUNCT
gjear-961	148	20	,	,	PUNCT
gjear-961	148	21	arthritis	arthritis	NOUN
gjear-961	148	22	&	&	CCONJ
gjear-961	148	23	allied	ally	VERB
gjear-961	148	24	conditions	condition	NOUN
gjear-961	148	25	.	.	PUNCT
gjear-961	149	1	a	a	DET
gjear-961	149	2	textbook	textbook	NOUN
gjear-961	149	3	of	of	ADP
gjear-961	149	4	rheumatology	rheumatology	NOUN
gjear-961	149	5	,	,	PUNCT
gjear-961	149	6	lippincott	lippincott	PROPN
gjear-961	149	7	,	,	PUNCT
gjear-961	149	8	williams	williams	PROPN
gjear-961	149	9	&	&	CCONJ
gjear-961	149	10	wilkins	wilkins	PROPN
gjear-961	149	11	:	:	PUNCT
gjear-961	149	12	baltimore	baltimore	PROPN
gjear-961	149	13	,	,	PUNCT
gjear-961	149	14	pp	pp	X
gjear-961	149	15	.	.	PUNCT
gjear-961	149	16	21992226	21992226	NUM
gjear-961	149	17	.	.	PUNCT
gjear-961	150	1	michel	michel	PROPN
gjear-961	150	2	,	,	PUNCT
gjear-961	150	3	g.	g.	PROPN
gjear-961	150	4	,	,	PUNCT
gjear-961	150	5	pojasek	pojasek	PROPN
gjear-961	150	6	,	,	PUNCT
gjear-961	150	7	k.	k.	PROPN
gjear-961	150	8	,	,	PUNCT
gjear-961	150	9	li	li	PROPN
gjear-961	150	10	,	,	PUNCT
gjear-961	150	11	y.	y.	PROPN
gjear-961	150	12	,	,	PUNCT
gjear-961	150	13	sulea	sulea	NOUN
gjear-961	150	14	,	,	PUNCT
gjear-961	150	15	t.	t.	NOUN
gjear-961	150	16	,	,	PUNCT
gjear-961	150	17	linhardt	linhardt	NOUN
gjear-961	150	18	,	,	PUNCT
gjear-961	150	19	r.	r.	PROPN
gjear-961	150	20	j.	j.	PROPN
gjear-961	150	21	,	,	PUNCT
gjear-961	150	22	raman	raman	PROPN
gjear-961	150	23	,	,	PUNCT
gjear-961	150	24	r.	r.	PROPN
gjear-961	150	25	&	&	CCONJ
gjear-961	150	26	cygler	cygler	PROPN
gjear-961	150	27	,	,	PUNCT
gjear-961	150	28	m.	m.	NOUN
gjear-961	150	29	(	(	PUNCT
gjear-961	150	30	2004	2004	NUM
gjear-961	150	31	)	)	PUNCT
gjear-961	150	32	.	.	PUNCT
gjear-961	151	1	the	the	DET
gjear-961	151	2	structure	structure	NOUN
gjear-961	151	3	of	of	ADP
gjear-961	151	4	chondroitin	chondroitin	PROPN
gjear-961	151	5	b	b	PROPN
gjear-961	151	6	lyase	lyase	NOUN
gjear-961	151	7	complexed	complexe	VERB
gjear-961	151	8	with	with	ADP
gjear-961	151	9	glycosaminoglycan	glycosaminoglycan	ADJ
gjear-961	151	10	oligosaccharides	oligosaccharide	NOUN
gjear-961	151	11	unravels	unravel	VERB
gjear-961	151	12	a	a	DET
gjear-961	151	13	calcium	calcium	NOUN
gjear-961	151	14	-	-	PUNCT
gjear-961	151	15	dependent	dependent	ADJ
gjear-961	151	16	catalytic	catalytic	ADJ
gjear-961	151	17	machinery	machinery	NOUN
gjear-961	151	18	.	.	PUNCT
gjear-961	152	1	journal	journal	NOUN
gjear-961	152	2	of	of	ADP
gjear-961	152	3	biological	biological	ADJ
gjear-961	152	4	chemistry	chemistry	NOUN
gjear-961	152	5	,	,	PUNCT
gjear-961	152	6	279(31	279(31	NUM
gjear-961	152	7	)	)	PUNCT
gjear-961	152	8	,	,	PUNCT
gjear-961	152	9	32882	32882	NUM
gjear-961	152	10	-	-	SYM
gjear-961	152	11	32896	32896	NUM
gjear-961	152	12	.	.	PUNCT
gjear-961	153	1	molnár	molnár	PROPN
gjear-961	153	2	-	-	NOUN
gjear-961	153	3	perl	perl	NOUN
gjear-961	153	4	,	,	PUNCT
gjear-961	153	5	i.	i.	NOUN
gjear-961	153	6	(	(	PUNCT
gjear-961	153	7	2011	2011	NUM
gjear-961	153	8	)	)	PUNCT
gjear-961	153	9	.	.	PUNCT
gjear-961	154	1	advancement	advancement	NOUN
gjear-961	154	2	in	in	ADP
gjear-961	154	3	the	the	DET
gjear-961	154	4	derivatizations	derivatization	NOUN
gjear-961	154	5	of	of	ADP
gjear-961	154	6	the	the	DET
gjear-961	154	7	amino	amino	NOUN
gjear-961	154	8	groups	group	NOUN
gjear-961	154	9	with	with	ADP
gjear-961	154	10	the	the	DET
gjear-961	154	11	o	o	ADJ
gjear-961	154	12	-	-	ADJ
gjear-961	154	13	phthaldehyde	phthaldehyde	ADJ
gjear-961	154	14	-	-	PUNCT
gjear-961	154	15	thiol	thiol	NOUN
gjear-961	154	16	and	and	CCONJ
gjear-961	154	17	with	with	ADP
gjear-961	154	18	the	the	DET
gjear-961	154	19	9fluorenylmethyloxycarbonyl	9fluorenylmethyloxycarbonyl	NUM
gjear-961	154	20	chloride	chloride	NOUN
gjear-961	154	21	reagents	reagent	NOUN
gjear-961	154	22	.	.	PUNCT
gjear-961	155	1	journal	journal	NOUN
gjear-961	155	2	of	of	ADP
gjear-961	155	3	chromatography	chromatography	PROPN
gjear-961	155	4	b	b	PROPN
gjear-961	155	5	,	,	PUNCT
gjear-961	155	6	879(17	879(17	NUM
gjear-961	155	7	-	-	SYM
gjear-961	155	8	18	18	NUM
gjear-961	155	9	)	)	PUNCT
gjear-961	155	10	,	,	PUNCT
gjear-961	155	11	1241	1241	NUM
gjear-961	155	12	-	-	SYM
gjear-961	155	13	1269	1269	NUM
gjear-961	155	14	.	.	PUNCT
gjear-961	156	1	qian	qian	PROPN
gjear-961	156	2	,	,	PUNCT
gjear-961	156	3	s.	s.	PROPN
gjear-961	156	4	,	,	PUNCT
gjear-961	156	5	zhang	zhang	PROPN
gjear-961	156	6	,	,	PUNCT
gjear-961	156	7	q.	q.	PROPN
gjear-961	156	8	,	,	PUNCT
gjear-961	156	9	wang	wang	PROPN
gjear-961	156	10	,	,	PUNCT
gjear-961	156	11	y.	y.	PROPN
gjear-961	156	12	,	,	PUNCT
gjear-961	156	13	lee	lee	PROPN
gjear-961	156	14	,	,	PUNCT
gjear-961	156	15	b.	b.	PROPN
gjear-961	156	16	,	,	PUNCT
gjear-961	156	17	betageri	betageri	PROPN
gjear-961	156	18	,	,	PUNCT
gjear-961	156	19	g.	g.	PROPN
gjear-961	156	20	v.	v.	PROPN
gjear-961	156	21	,	,	PUNCT
gjear-961	156	22	chow	chow	PROPN
gjear-961	156	23	,	,	PUNCT
gjear-961	156	24	m.	m.	NOUN
gjear-961	156	25	s.	s.	PROPN
gjear-961	156	26	,	,	PUNCT
gjear-961	156	27	...	...	PUNCT
gjear-961	156	28	&	&	CCONJ
gjear-961	156	29	zuo	zuo	PROPN
gjear-961	156	30	,	,	PUNCT
gjear-961	156	31	z.	z.	PROPN
gjear-961	156	32	(	(	PUNCT
gjear-961	156	33	2013	2013	NUM
gjear-961	156	34	)	)	PUNCT
gjear-961	156	35	.	.	PUNCT
gjear-961	157	1	bioavailability	bioavailability	NOUN
gjear-961	157	2	enhancement	enhancement	NOUN
gjear-961	157	3	of	of	ADP
gjear-961	157	4	glucosamine	glucosamine	NOUN
gjear-961	157	5	hydrochloride	hydrochloride	NOUN
gjear-961	157	6	by	by	ADP
gjear-961	157	7	chitosan	chitosan	NOUN
gjear-961	157	8	.	.	PUNCT
gjear-961	158	1	international	international	ADJ
gjear-961	158	2	journal	journal	PROPN
gjear-961	158	3	of	of	ADP
gjear-961	158	4	pharmaceutics	pharmaceutic	NOUN
gjear-961	158	5	,	,	PUNCT
gjear-961	158	6	455(12	455(12	NUM
gjear-961	158	7	)	)	PUNCT
gjear-961	158	8	,	,	PUNCT
gjear-961	158	9	365	365	NUM
gjear-961	158	10	-	-	SYM
gjear-961	158	11	373	373	NUM
gjear-961	158	12	.	.	PUNCT
gjear-961	159	1	redón	redón	PROPN
gjear-961	159	2	,	,	PUNCT
gjear-961	159	3	l.	l.	PROPN
gjear-961	159	4	,	,	PUNCT
gjear-961	159	5	subirats	subirat	NOUN
gjear-961	159	6	,	,	PUNCT
gjear-961	159	7	x.	x.	PROPN
gjear-961	159	8	&	&	CCONJ
gjear-961	159	9	rosés	rosés	PROPN
gjear-961	159	10	,	,	PUNCT
gjear-961	159	11	m.	m.	NOUN
gjear-961	159	12	(	(	PUNCT
gjear-961	159	13	2020	2020	NUM
gjear-961	159	14	)	)	PUNCT
gjear-961	159	15	.	.	PUNCT
gjear-961	160	1	hilic	hilic	ADJ
gjear-961	160	2	characterization	characterization	NOUN
gjear-961	160	3	:	:	PUNCT
gjear-961	160	4	estimation	estimation	NOUN
gjear-961	160	5	of	of	ADP
gjear-961	160	6	phase	phase	NOUN
gjear-961	160	7	volumes	volume	NOUN
gjear-961	160	8	and	and	CCONJ
gjear-961	160	9	composition	composition	NOUN
gjear-961	160	10	for	for	ADP
gjear-961	160	11	a	a	DET
gjear-961	160	12	zwitterionic	zwitterionic	ADJ
gjear-961	160	13	column	column	NOUN
gjear-961	160	14	.	.	PUNCT
gjear-961	161	1	analytica	analytica	PROPN
gjear-961	161	2	chimica	chimica	PROPN
gjear-961	161	3	acta	acta	PROPN
gjear-961	161	4	,	,	PUNCT
gjear-961	161	5	1130	1130	NUM
gjear-961	161	6	,	,	PUNCT
gjear-961	161	7	39	39	NUM
gjear-961	161	8	-	-	SYM
gjear-961	161	9	48	48	NUM
gjear-961	161	10	.	.	PUNCT
gjear-961	162	1	stanley	stanley	PROPN
gjear-961	162	2	,	,	PUNCT
gjear-961	162	3	r.	r.	PROPN
gjear-961	162	4	&	&	CCONJ
gjear-961	162	5	mohler	mohler	PROPN
gjear-961	162	6	,	,	PUNCT
gjear-961	162	7	m.d	m.d	PROPN
gjear-961	162	8	.	.	PROPN
gjear-961	162	9	(	(	PUNCT
gjear-961	162	10	2004	2004	NUM
gjear-961	162	11	)	)	PUNCT
gjear-961	162	12	.	.	PUNCT
gjear-961	163	1	prompt	prompt	ADJ
gjear-961	163	2	treatment	treatment	NOUN
gjear-961	163	3	may	may	AUX
gjear-961	163	4	minimize	minimize	VERB
gjear-961	163	5	knee	knee	NOUN
gjear-961	163	6	problems	problem	NOUN
gjear-961	163	7	and	and	CCONJ
gjear-961	163	8	their	their	PRON
gjear-961	163	9	interference	interference	NOUN
gjear-961	163	10	with	with	ADP
gjear-961	163	11	flight	flight	NOUN
gjear-961	163	12	duties	duty	NOUN
gjear-961	163	13	–	–	PUNCT
gjear-961	163	14	and	and	CCONJ
gjear-961	163	15	daily	daily	ADJ
gjear-961	163	16	routines	routine	NOUN
gjear-961	163	17	.	.	PUNCT
gjear-961	164	1	human	human	ADJ
gjear-961	164	2	factors	factor	NOUN
gjear-961	164	3	&	&	CCONJ
gjear-961	164	4	aviation	aviation	NOUN
gjear-961	164	5	medicine	medicine	NOUN
gjear-961	164	6	,	,	PUNCT
gjear-961	164	7	51(4	51(4	NUM
gjear-961	164	8	)	)	PUNCT
gjear-961	164	9	,	,	PUNCT
gjear-961	164	10	1	1	NUM
gjear-961	164	11	-	-	SYM
gjear-961	164	12	7	7	NUM
gjear-961	164	13	.	.	PUNCT
gjear-961	165	1	uebelhart	uebelhart	PROPN
gjear-961	165	2	,	,	PUNCT
gjear-961	165	3	d.	d.	PROPN
gjear-961	165	4	(	(	PUNCT
gjear-961	165	5	2008	2008	NUM
gjear-961	165	6	)	)	PUNCT
gjear-961	165	7	.	.	PUNCT
gjear-961	166	1	clinical	clinical	ADJ
gjear-961	166	2	review	review	NOUN
gjear-961	166	3	of	of	ADP
gjear-961	166	4	chondroitin	chondroitin	NOUN
gjear-961	166	5	sulfate	sulfate	NOUN
gjear-961	166	6	in	in	ADP
gjear-961	166	7	osteoarthritis	osteoarthritis	NOUN
gjear-961	166	8	.	.	PUNCT
gjear-961	167	1	osteoarthritis	osteoarthritis	NOUN
gjear-961	167	2	and	and	CCONJ
gjear-961	167	3	cartilage	cartilage	NOUN
gjear-961	167	4	,	,	PUNCT
gjear-961	167	5	16	16	NUM
gjear-961	167	6	,	,	PUNCT
gjear-961	167	7	s19	s19	NOUN
gjear-961	167	8	-	-	PUNCT
gjear-961	167	9	s21	s21	NOUN
gjear-961	167	10	.	.	PUNCT
gjear-961	168	1	united	united	PROPN
gjear-961	168	2	states	states	PROPN
gjear-961	168	3	pharmacopoeia	pharmacopoeia	PROPN
gjear-961	168	4	(	(	PUNCT
gjear-961	168	5	usp	usp	PROPN
gjear-961	168	6	,	,	PUNCT
gjear-961	168	7	40	40	NUM
gjear-961	168	8	)	)	PUNCT
gjear-961	168	9	.	.	PUNCT
gjear-961	169	1	7019	7019	NUM
gjear-961	169	2	-	-	SYM
gjear-961	169	3	1021	1021	NUM
gjear-961	169	4	.	.	PUNCT
gjear-961	170	1	václavíková	václavíková	PROPN
gjear-961	170	2	,	,	PUNCT
gjear-961	170	3	e.	e.	PROPN
gjear-961	170	4	&	&	CCONJ
gjear-961	170	5	kvasnička	kvasnička	PROPN
gjear-961	170	6	,	,	PUNCT
gjear-961	170	7	f.	f.	PROPN
gjear-961	170	8	(	(	PUNCT
gjear-961	170	9	2015	2015	NUM
gjear-961	170	10	)	)	PUNCT
gjear-961	170	11	.	.	PUNCT
gjear-961	171	1	quality	quality	NOUN
gjear-961	171	2	control	control	NOUN
gjear-961	171	3	of	of	ADP
gjear-961	171	4	chondroitin	chondroitin	NOUN
gjear-961	171	5	sulphate	sulphate	NOUN
gjear-961	171	6	used	use	VERB
gjear-961	171	7	in	in	ADP
gjear-961	171	8	dietary	dietary	ADJ
gjear-961	171	9	supplements	supplement	NOUN
gjear-961	171	10	.	.	PUNCT
gjear-961	172	1	czech	czech	PROPN
gjear-961	172	2	journal	journal	PROPN
gjear-961	172	3	of	of	ADP
gjear-961	172	4	food	food	NOUN
gjear-961	172	5	sciences	science	NOUN
gjear-961	172	6	,	,	PUNCT
gjear-961	172	7	33(2	33(2	NUM
gjear-961	172	8	)	)	PUNCT
gjear-961	172	9	,	,	PUNCT
gjear-961	172	10	165	165	NUM
gjear-961	172	11	-	-	SYM
gjear-961	172	12	173	173	NUM
gjear-961	172	13	.	.	PUNCT
gjear-961	173	1	vietnam	vietnam	PROPN
gjear-961	173	2	ministry	ministry	PROPN
gjear-961	173	3	of	of	ADP
gjear-961	173	4	public	public	PROPN
gjear-961	173	5	health	health	PROPN
gjear-961	173	6	(	(	PUNCT
gjear-961	173	7	vmph	vmph	PROPN
gjear-961	173	8	,	,	PUNCT
gjear-961	173	9	2018	2018	NUM
gjear-961	173	10	)	)	PUNCT
gjear-961	173	11	.	.	PUNCT
gjear-961	174	1	vietnam	vietnam	PROPN
gjear-961	174	2	pharmacopoeia	pharmacopoeia	PROPN
gjear-961	174	3	v	v	PROPN
gjear-961	174	4	,	,	PUNCT
gjear-961	174	5	medical	medical	ADJ
gjear-961	174	6	publishing	publishing	NOUN
gjear-961	174	7	house	house	PROPN
gjear-961	174	8	,	,	PUNCT
gjear-961	174	9	454455	454455	NUM
gjear-961	174	10	.	.	PUNCT